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Acute pancreatitis is a potentially severe inflammatory disease that may be associated
with a substantial morbidity and mortality. Currently there is no specific treatment for
the disease, which indicates an ongoing demand for research into its pathogenesis and
development of new therapeutic strategies. Due to the unpredictable course of acute
pancreatitis and relatively concealed anatomical site in the retro-peritoneum, research on
the human pancreas remains challenging. As a result, for over the last 100 years studies
on the pathogenesis of this disease have heavily relied on animal models. This review
aims to summarize different animal models of acute pancreatitis from the past to present
and discuss their main characteristics and applications. It identifies key studies that
have enhanced our current understanding of the pathogenesis of acute pancreatitis and
highlights the instrumental role of animal models in translational research for developing
novel therapies.
Keywords: acute pancreatitis, animal models, pancreatic acinar cells, pancreatic stellate cells, pancreatic ductal
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INTRODUCTION
Acute pancreatitis (AP) is an inflammatory disorder of the pancreas, which ranges from mild,
self-limiting disease to a severe form that is associated with multiple organ dysfunction syndrome
(MODS), high morbidity, and mortality (Hines and Pandol, 2019). Although in the last two
decades advances have been made in the supportive management of AP, specific, and effective drug
treatment is still lacking due to the poorly understood pathobiology of the disease (Moggia et al.,
2017). Ideally, studies on the etiology, pathogenesis, and treatment of AP should be carried out
on the human pancreas. However, the unpredictable nature of the disease, heterogeneity of disease
presentations, and limited access to human samples, make research on human tissues impractical
and often very difficult. For these reasons, experimental models have been widely used to study
AP for more than a century (Gorelick and Lerch, 2017). In recent years, the most commonly
used AP models are carried out on rodents (rats and mice), which are relatively inexpensive to
maintain, easy to handle, accessible, and allow induction of moderate to severe pancreatic injury.
These experimental models not only provide an opportunity for mechanistic studies but also enable
development of therapeutic strategies.
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What makes a perfect animal model? Ideally it should reflect
the etiology, pathobiology, histopathology, the clinical course,
and outcome of the disease in humans. However, these aims are
impossible to reproduce all in one model. Our knowledge of
mechanisms relevant to the human condition, the multitude of
genetic and environmental factors that are likely to influence the
risk of disease development and the natural history of the disease
remains lacking (Gorelick and Lerch, 2017). Hence, the crucial
consideration for researchers selecting a model for research
studies is “What is the specific research question being asked by
the study?.” Experimental AP models can be divided into in vivo
and in vitromodels. Further in vivo experimental AP models can
be generally sub-divided into non-invasive and invasive models.
Although these categories describe the logistic differences in
inducing each respective model, certain models may have greater
utility over others dependent on which mechanisms they focus
on, which animal species they are induced in, and which disease
outcomes are reproduced. Here we comprehensively review the
history, development, and current use of important experimental
AP models as well as explore their mechanisms, advantages,
limitations, clinical relevance, and the scope for future work.
CAERULEIN/CHOLECYSTOKININ
Early in 1895, Mouret (1895) found that excessive cholinergic
stimulation causes vacuolization and necrosis of the pancreas,
which are typical features of AP. Later in 1929, Villaret et al.
(1929) reported the first secretagogue hyperstimulation-induced
APmodel by injection of acetylcholine, a cholinergic agonist, into
the canine pancreas and this was later reproduced in a rat model
(Leblond and Sergeyeva, 1944). Subsequently, cholecystokinin
octapeptide (CCK-8) and its analog caerulein (Lampel and
Kern, 1977), as well as carbamylcholine (Adler et al., 1983),
anticholinesterase (Dressel et al., 1982), and scorpion toxin
(Gallagher et al., 1981; Pantoja et al., 1983; Novaes et al., 1989)
have been shown to induce AP.
CCK was named after its main function related to promoting
contraction of gallbladder smooth muscle and bile discharge
(Ivy, 1929). Later, it was found that it can act on the
pancreas to stimulate the secretion of pancreatic digestive
enzymes (Harper and Raper, 1943) and insulin (Kuntz et al.,
2004). The fundamental mechanism of pancreatic pathology
induced by CCK and its analogs is based on the action of
these chemicals on CCK receptors, which in turn leads to
activation of second messenger pathways related to secretion
of pancreatic enzymes (e.g., amylase) in pancreatic acinar
cells (PACs) like phospholipase C-inositol trisphosphate-calcium
(Ca2+). There are also protein-protein interaction pathways that
mainly regulate non-secretory processes, including biosynthesis
and growth, such as three major mitogen-activated protein
kinase pathways (ERK, JNK, and p38 MAPK) and several other
pathways that are still unknown. While CCK-8 is most well-
studied, CCK-58 is the main circulating form in humans and
dogs, and the only endocrine form of CCK-58 in rats (Reeve
et al., 2004). CCK-8 and CCK-58 have the same effect on Ca2+
signaling, zymogen activation, and cell death in PACs at high and
low agonist concentrations in vitro (Criddle et al., 2009). A recent
review has summarized the regulation of the CCK pathway in
PACs in detail (Williams, 2019).
Caerulein, a CCK analog, was first isolated from skin
extracts of the Australian green tree frog (Litoria caerulea)
and was immediately acknowledged for its physiological activity
mimicking natural hormones (Anastasi et al., 1968). CCK and
caerulein have a very similar amino acid sequence, but compared
to the CCK, caerulein is a decapeptide that has methionine
substituted to threonine and two additional N-terminal residues
(Figure 1A). Both peptides show almost the same potency
in vitro, but caerulein is more potent to induce AP in vivo
(Figure 1B). The increased biological activity is related to the
additional N-terminal residues, and a result of the substitution
of methionine for threonine (Shorrock et al., 1991). To date,
caerulein remains the most widely used compound to induce AP
(CER-AP) in rodents.
There is a clear dose-response relationship between the
structural and biochemical changes of the pancreas in response
to caerulein administration (Bieger et al., 1976b). Continuous
infusion of maximal physiological doses of caerulein (0.25
µg/kg/h) causes rapid degranulation of the exocrine pancreas in
rats (Bieger et al., 1976a). Administration with a supramaximal
dose leads to vacuolization within the acinar cells, followed by
regeneration of the pancreas (Tardini et al., 1971). At an even
higher dose, caerulein causes pancreatic interstitial edema and
inflammatory cell infiltration together with a significant increase
of the pancreatic enzyme levels in the blood (Willemer et al.,
1992). Based on the above findings, in 1977 Lampel and Kern
(1977) described a non-lethal CER-AP model in rats, after which
CER-AP was successfully reproduced in mice (Niederau et al.,
1985).
CCK and its analogs were shown to induce pancreatic injury
in a time-dependent manner in addition to a dose-dependent
manner (Watanabe et al., 1984). One of the early consequences
of hyperstimulation with caerulein is the formation of pancreatic
oedema. This may be due to increased vascular permeability
and hydrostatic pressure (Lerch et al., 1995b; Weidenbach et al.,
1995). However, the exact mechanism leading to the formation
of extensive oedema is still not fully understood as it does not
reflect the extent of damage to PACs. This model is now widely
used for the analysis of early intracellular events in AP. Although
the pancreatic injury can be controlled by appropriate dosage and
frequency of injections (Figure 1C) and the pancreas begins to
recover after reaching its peak over time (Figure 1D), this model
is generally self-limiting without MODS and lethality, which may
be its biggest limitation.
To address this limitation, caerulein is often combined with
other compounds to achieve increased severity of CER-AP. For
example, lipopolysaccharide (LPS) in CER-AP (Sugita et al.,
1997; Yamaguchi et al., 1999; Chao et al., 2006) exaggerates the
inflammatory response and MODS, mimicking AP-associated
sepsis. Infusion of rats with enterokinase (EK) after caerulein
administration causes pancreatic necrosis, hemorrhage, and high
mortality rates (Hartwig et al., 2007). Similar effects can also
be replicated in mice (Hartwig et al., 2008), making it possible
to undertake transgenic studies. Therefore, the “two-hit” model
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FIGURE 1 | Structure of cholecystokinin and caerulein and their effects on pancreas. (A) Structure of cholecystokinin (CCK) and caerulein (CER). Pyr, pyroglutamic
acid. (B) Comparison of the potency of CCK and CER in inducing acute pancreatitis (AP). Mice received seven intraperitoneal (i.p.) injections of CCK (50 or 100 µg/kg;
(Continued)
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FIGURE 1 | MW: 1142.20), CER (50 µg/kg; MW: 1,352.40), or normal saline at hourly intervals. Mice were sacrificed 12 h after the first injection. While CER induced
typical features of AP (edema, vacuolization, inflammatory cell infiltration, and necrosis), CCK at both doses did not cause disenable pancreas histopathological
changes. (C) Comparison of the efficacy of different injection regimens of CER in inducing AP. Mice received i.p. injection of CER (50 µg/kg) or normal saline at 1 h
apart. The mice were killed 12 h after the first injection. After 4 injections of CER, there were focally increased edema between lobules, periductal neutrophil infiltration,
and minimal acinar cell necrosis; after 8 injections of CER, there were diffusely increased edema, parenchyma neutrophil infiltration, and periductal and focal acinar cell
necrosis; after 12 injections of CER, there were disrupted and separated acini structure, marked parenchyma neutrophil infiltration, and focal and diffuse parenchymal
necrosis. (D) Comparison pancreatic changes at different time after AP induced by 8 injections of CER. Mice received 8 times i.p. injection of CER (50 µg/kg) or
normal saline at 1 h apart. At 8 h, there were marked pancreas histopathological changes, which peaked at 12 h and started to recover at 24 h. All experiments used
C57BL/6J mice and the images were at magnification of × 200.
induced by caerulein with LPS or EK, is a useful tool to study
inflammatory changes, sepsis, and bacterial translocation in AP
(Xue et al., 2009). Whereas, one must remember that although
the additional administration of LPS or EK results in a greater
immune response in this setting, AP, at least on initiation, is
primarily a sterile inflammation and this aspect of the disease is
quite difficult to model.
The caerulein/CCK model exhibits the closest parallel with
clinical AP induced by scorpion venom or organophosphate
insecticides. It is non-invasive, easy to conduct, highly
reproducible, reflects a vast number of in vitro studies, making it
a favorable model for AP. It is also compatible with other models,
sharing histopathological changes consistent with early phases
of human AP (Rifai et al., 2008). All these factors explain why
CER-AP is so widely accepted and commonly used by pancreatic
investigators (Saluja et al., 2007; Lerch and Gorelick, 2013).
BASIC AMINO ACIDS
Intraperitoneal (i.p.) administration of excessive doses of certain
amino acids, such as L-arginine (Toma et al., 2000), L-ornithine
(Rakonczay et al., 2008), L-lysine (Biczo et al., 2011b), and L-
histidine (Zhang et al., 2018), causes necrotising AP in rats and/or
mice. Why these particular basic amino acids induce AP has not
yet been fully clarified, but is likely related to shared metabolic
pathways in vivo determined by the structural similarities.
L-Arginine
L-arginine-induced AP (ARG-AP) is currently the most
commonly used amino acid-induced AP model in rats and mice.
The effect of L-arginine on the pancreas has been extensively
investigated since 1984, when single i.p. injection of L-arginine
at 5 g/kg led to long lasting PAC and adipose tissue necrosis
in the rat pancreas, without affecting islets and other organs
(Mizunuma et al., 1984). These findings were further confirmed
in the same year (Kishino and Kawamura, 1984). Higher doses
(7.5 g/kg) of L-arginine can be lethal for experimental animal,
whereas a dose of 2.5 g/kg only caused mild pancreatic injury. In
addition, severe AP can be induced in mice by i.p. injection of
L-arginine in two doses of 4 g/kg each, at 1 h apart (Dawra et al.,
2007). Subsequently, in various studies either single or double
injections of L-arginine were applied at different doses to induce
necrotising AP in rats or mice. It is worth noting that when using
the AP model induced by L-arginine, the dose, concentration,
pH of L-arginine, and the strain of mice must be taken into
account (Kui et al., 2015) and that D-arginine has no effect on
the pancreas (Dawra et al., 2007). Severe acute inflammation of
the mouse pancreas induced by L-arginine is classically followed
by lung injury. There is a certain failure rate and mortality rate
in this model (Hegyi et al., 2004). ARG-AP model is rarely fatal
in rats, but it has a mortality rate of 5–7% in mice (Dawra and
Saluja, 2012). In our laboratory, we induced AP in C57BL/6J
mice (∼25 g) with 4 g/kg × 2 of L-arginine, and the mortality
was 1∼3%. Moreover, the mortality usually occurs within a few
hours after the second injection, and before AP occurs, it may be
caused by metabolic disorder caused by excessive amino acids.
The mechanisms of AP induced by L-arginine remain unclear.
Amino acid imbalance (Mizunuma et al., 1984), reactive oxygen
species (Czako et al., 1998; Rakonczay et al., 2003), inflammatory
mediators (Czako et al., 2000; Takacs et al., 2002b; Rakonczay
et al., 2003), nitric oxide (Takacs et al., 2002a), cytoskeletal
changes (Tashiro et al., 2001), intracellular Ca2+ signaling (Zhang
et al., 2018), mitochondrial dysfunction (Biczo et al., 2018; Zhang
et al., 2018) and endoplasmic reticulum stress (Kubisch et al.,
2006) have all been postulated to be involved in this process.
L-Ornithine
Rakonczay et al. reported a simple, non-invasive model of
necrotising AP induced by i.p. injection of 3 g/kg L-ornithine,
which is even more effective than L-arginine in rats (Rakonczay
et al., 2008). Since L-ornithine is a product of L-arginine
metabolism in vivo (in the urea cycle), it is inferred that
large doses of L-arginine cause pancreatic injury at least
partially through L-ornithine (Figure 2A). Biczo et al. found that
pancreatic polyamine catabolism was activated in L-ornithine-
induced AP, and tried to ameliorate it with metabolically stable
polyamine analogs, which turned out ineffective (Biczo et al.,
2010). We also tried to induce AP with L-ornithine (2 × 4 g/kg)
in mice, but found the model to be excessively severe and mice
were dead within few hours (Zhang et al., 2018).
L-Lysine
In vivo administration of L-lysine causes early mitochondrial
damage as evidenced by degenerated mitochondria shown
by electron microscopy and impaired ATP synthase activity
in mitochondria of isolated PACs (Biczo et al., 2011b).
The mitochondrial injury appears prior to the activation of
trypsinogen and nuclear factor kappa-B (NF-κB) (Biczo et al.,
2011b) which suggests that the aliphatic amino acid might be
more likely to cause AP due to its positive charge and L-lysine
induces mitochondria injury.
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FIGURE 2 | Ornithine cycle and molecular structure of basic amino acids. (A) Ornithine cycle. Arginine is partially metabolized into ornithine in vivo. (B) Molecular
structure of basic amino acids inducing acute pancreatitis in rodents. Large doses of L-arginine, L-ornithine, L-lysine, and L-histidine have been proven to induce
severe acute pancreatitis.
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TABLE 1 | Effect of different amino acids on the pancreas in vivo.
Amino acids Dose Injection Species Pancreatic injury References
L-arginine 2.5 g/kg Single Rats No obvious pancreatic damage Pozsar et al., 1997; Tashiro et al.,
2001; Hardman et al., 2005
3.0 g/kg Single Rats Mild pancreatic injury, e.g., focal acinar cell
necrosis
Tashiro et al., 2001; Rakonczay
et al., 2003
4.0–5.0 g/kg Single Rats AP with consistent moderate severity, extensive
acinar cell necrosis
Shields et al., 2001; Tashiro et al.,
2001; Takacs et al., 2002b;
Rakonczay et al., 2003; Kubisch
et al., 2006
2.0–3.2 g/kg × 2 Twice at 1 h interval Rats Severe acute necrotising pancreatitis Takacs et al., 1996, 2001, 2002b;
Hegyi et al., 1997, 1999, 2000;
Szabolcs et al., 2006
3 g/kg × 2 Twice at 1 h interval Rats Severe acute necrotising pancreatitis Biczo et al., 2018
3.3 g/kg × 3 Three times at 1 h interval Mice Severe acute necrotising pancreatitis Biczo et al., 2018
4.0 g/kg × 2 Twice at 1 h interval Mice Severe acute necrotising pancreatitis Dawra et al., 2007
D-arginine 4.0 g/kg × 2 Twice at 1 h interval Mice No obvious pancreatic damage Dawra et al., 2007
L-alanine 4.0 g/kg × 2 Twice at 1 h interval Mice No obvious pancreatic damage Dawra et al., 2007
Glycine 4.0 g/kg Single Mice No obvious pancreatic damage, two doses
causing high mortality
Dawra et al., 2007
L-ornithine 3.0 g/kg Single Rats Severe acute necrotising pancreatitis Rakonczay et al., 2008
4.0 g/kg × 2 Twice at 1 h interval Mice All mice died within a few hours after injection Zhang et al., 2018
L-citrulline 2.9 g/kg Single Rats No obvious pancreatic damage Rakonczay et al., 2008
L-lysine 2.0 g/kg Single Rats Severe acute necrotising pancreatitis Biczo et al., 2011b
4.0 g/kg × 2 Twice at 1 h interval Mice No obvious pancreatic damage Dawra et al., 2007
L-histidine 3.0 g/kg Single Rats No obvious pancreatic damage Biczo et al., 2011a
4.0 g/kg × 2 Twice at 1 h interval Mice Severe necrotising pancreatitis Zhang et al., 2018
L-Histidine
Although previous studies showed that i.p. injection of 3 g/kg L-
histidine had no effect on the rat pancreas (Biczo et al., 2011a),
our group reported for the first time that i.p. administration of 2
× 4 g/kg L-histidine (1 h apart) to mice can induce AP (Zhang
et al., 2018). L-histidine at a dose of >3 g/kg could also likely
trigger AP in rats, but this has not yet been tested. One of the
potential limitations is the relatively low solubility of L-histidine
in physiological saline, which requires larger amounts of liquid
for injections of higher concentrations of the amino acid.
The effects of different amino acids on the pancreas are
summarized in Table 1. These AP models have a well-defined,
gradually progressive pancreatic necrosis, and associated lung
injury. Therefore, they are suitable for addressing the molecular
mechanisms and regenerative processes in necrotising AP.
We used L-arginine, L-ornithine, and L-histidine and found
significant differences in the mechanism of pancreatic injury
induced by different basic amino acids (Zhang et al., 2018). Our
data indicate that the metabolism of L-arginine to L-ornithine
is involved in the pathogenesis of AP induced by L-arginine
(Zhang et al., 2018). It is noteworthy that basic amino acids
with aliphatic side chains (Figure 2B) appear to be more effective
inducers of AP. It is well-known that hereditary diseases of
branched chain amino acid metabolism will greatly increase the
risk of AP in human beings (Lerch et al., 2006). Therefore,
the model of AP induced by amino acids may also have links
to human disease. However, it must be remembered that in
clinical settings human AP caused by overdose of amino acids is
rare (Saka et al., 2004).
ETHANOL AND FREE FATTY ACIDS
Alcohol is the second leading cause of AP worldwide (Petrov
and Yadav, 2019). However, the mechanisms whereby ethanol
exerts its deleterious effects are still relatively poorly understood
(Clemens et al., 2016). Early animal experimental findings
from acute ethanol administration via various routes have
shown that alcohol increases pancreatic duct permeability,
reduces pancreatic blood flow and microcirculation (Friedman
et al., 1983; Foitzik et al., 1998), decreases pancreatic oxygen
consumption (Foitzik et al., 1995), and induces oxidative stress
(Weber et al., 1995). Whereas, ethanol alone fails to cause AP,
which is in line with the human disease: since <5% alcoholics
will develop clinical AP (Forsmark et al., 2016). Instead, it
appears that the pancreas is sensitized to injury by alcohol
consumption, and an additional factor trigger initiation of the
alcohol-associated pancreatic injury. There is a dose-dependent
sensitization of ethanol to CCK (or caerulein)- or bile acid-
mediated PAC injury in vitro (Katz et al., 1996; Lu et al., 2002)
and pancreatic damage in vivo (Foitzik et al., 1994; Andrzejewska
et al., 1998; Pandol et al., 1999). A recent report showed
that although alcohol feeding does not cause experimental AP,
endoplasmic reticulum stress, and cell death of PACs can be
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FIGURE 3 | Ethanol metabolism and fatty acid ethyl ester-induced acute pancreatitis. (A) Non-oxidative and oxidative ethanol metabolism pathways. AHD, alcohol
dehydrogenase; P450, cytochrome P450; ALDH, aldehyde dehydrogenase; 4-MP, 4-methylpyrazole; FAs, fatty acids; FAEEs, fatty acid ethyl esters; 3-BCP,
3-benzyl-6-chloro-2-pyrone. (B) A schematic of fatty acid ethyl ester-induced acute pancreatitis (FAEE-AP) in mice. The model was induced by concomitant
administration of ethanol (1.35 g/kg) and palmitoleic acid (POA, 150 mg/kg). (C) Representative H&E images of pancreas histopathological slides of FAEE-AP (Huang
et al., 2014).
triggered upon simultaneous exposure to ethanol and cigarette
smoke (Lugea et al., 2017a). As a consequence, ethanol has been
considered a key aggravating factor in the development of AP.
On the other hand, ethanol metabolites by both oxidative
and non-oxidative pathways (Figure 3A) have been shown to
cause a number of changes that can predispose the pancreas to
AP (Laposata and Lange, 1986). The oxidative metabolism of
ethanol is catalyzed by alcohol dehydrogenase and cytochrome
P450 2E1, resulting in the production of reactive oxygen species
and acetaldehyde (Wilson and Apte, 2003; Cederbaum, 2012).
Oxidative metabolism of ethanol has also been shown to sensitize
pancreatic mitochondria to activate mitochondrial permeability
transition pore, leading to mitochondrial failure (Shalbueva et al.,
2013).
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Non-oxidative ethanol metabolism is accomplished by a
diverse group of enzymes known as fatty acid ethyl ester
(FAEE) synthases, which combines free fatty acids (FFAs) with
ethanol generating FAEEs (Wilson and Apte, 2003; Zelner
et al., 2013). Alcohol consumption is associated with elevated
plasma triglycerides, impaired lipolysis, and increased FFAs
fluxes from adipose tissue to the liver (Klop et al., 2013). And high
concentrations of FFAs are noted in the serum and pancreatic
necrosis debridement fluid of patients with AP (Sztefko and
Panek, 2001; Navina et al., 2011; Patel et al., 2015; Noel et al.,
2016). The pancreas is particularly rich in FAEE synthases,
hence the relatively high accumulation of FAEEs in this organ
(Laposata and Lange, 1986; Gukovskaya et al., 2002). Direct
evidence that FAEEs cause some features of AP comes from
Werner et al. (2002). They found that when an ethanol infusion
was combined with inhibitors of the oxidative pathway of
alcohol metabolism, the injury to the pancreas was exacerbated
compared to ethanol alone, and the extent of pancreatic injury
was dependent on the formation of FAEEs (Werner et al., 2002).
This observation fits in with the previous post-mortem findings
demonstrating the presence of high concentrations of FAEEs in
the pancreas of patients with acute alcohol intoxication at the
time of death (Ishii et al., 1986). Direct intravenous infusion of
FAEEs also induces pancreatic oedema, pancreatic trypsinogen
activation, and vacuolisation in the pancreas (Werner et al.,
1997). Subsequently, in vitro data from our group have shown
that FAEEs at relatively low concentrations (10–100µM) cause
prominent cytosolic Ca2+ rises, leading to the impairment of
the mitochondrial functions and subsequent necrosis of PACs
(Criddle et al., 2006).
Based on the available literature from in vitro and in vivo
studies, we postulated that a more etiologically relevant model
could be developed by concomitant administration of fatty
acids and non-toxic concentrations of ethanol (Huang et al.,
2014). To study the effect of FAEEs on AP initiation, we i.p.
injected ethanol (1.35 g/kg) and palmitoleic acid (150 mg/kg),
a monounsaturated fatty acid, for two times (Figure 3B), and
successfully induced pancreatic injury in mice, including marked
pancreatic oedema, neutrophil infiltration, and local necrosis
(Figure 3C). This model also causes thickening of alveolar
membrane and infiltration of inflammatory cells in the lung, but
there is no or very little effect on the liver, kidney or heart (Huang
et al., 2014). Other groups reproduced this model with different
FFAs, such as ethanol (1.32 g/kg) and palmitoleic acid (2 mg/kg)
in mice (Vigna et al., 2014), ethanol (1.75 g/kg), and palmitic acid
(750mg/kg) inmice (Maleth et al., 2015), ethanol (1.35 g/kg), and
palmitoleic acid (2 or 150mg/kg) in hamsters (Wang et al., 2016).
The lack of a widely accepted alcohol-induced AP model
in pancreatology remains a drawback in the study of alcoholic
AP. The existing animal models are to date the best research
tools, amongst which the Lieber-DeCarli method (Bertola et al.,
2013) is the most widely used experimental model to study
alcoholic diseases in rodents. The fact that AP does not occur
in all patients with alcohol abuse in a clinical environment
strongly suggests other factors must play a role in determining
individual susceptibility. Future models based on transgenic
mice harboring genetic predisposing variants combined with the
administration of alcohol or its metabolites may prove to be
more useful.
BILE ACIDS
Although a variety of experimental AP models have been
described, the clinical relevance of these models might be
questioned due to the fact that they do not depend on the
replication of events that are considered clinically triggering AP.
One of such events is biliary reflux into the pancreas through the
pancreatic duct, which is believed to be the most common cause
of AP in humans (Lerch and Aghdassi, 2010).
After the pancreatic duct infusion-induced AP (PDI-
AP) report by Bernard (1856), bile salts such as sodium
chenodeoxycholate, sodium taurocholate (NaTC), sodium
glycodeoxycholic acid, taurodeoxycholate, and taurolithocholic
acid 3-sulfate (TLCS) have been used to induce PDI-AP in
different species. In these models, pancreatic injury develops
rapidly and is limited to the pancreatic head and body, while the
pancreatic tail is much less affected. Since this model requires
retrograde pancreatic duct injection, the degree of pancreatic
damage is closely related to the pressure in the pancreatic duct,
the type of inducer and the injection speed. Manual injection
may not be steady enough, and micro-dose liquid medicine
injection pump should be used instead. The frequently used
PDI-AP animal models induced by bile acids in rodents are
summarized in Table 2 and the recent advances have been
reviewed elsewhere (Wan et al., 2012).
Among these bile salts, the taurine-conjugated bile salt NaTC
is the most widely used and best characterized thus far for
inducing PDI-AP. The rat model of NaTC infusion provides a
well-defined tool to research MODS in severe AP, mirroring the
human condition. This model has high mortality rates of 24–
100% (Silva-Vaz et al., 2019) and the mortality increases with the
amount of NaTC injected. Similarly to the caerulein/LPS model,
this model is suitable for studying bacterial translocation when
combined with LPS (Yamanel et al., 2005). When the NaTC/LPS
model is supplemented with trypsin, even more severe MODS is
produced (Yamano et al., 1998).
A non-lethal PDI-AP model (Laukkarinen et al., 2007)
produced necrotising AP in the head of the pancreas without
associated lung injury. This validated mouse model (Wittel
et al., 2008; Ziegler et al., 2011) allows for standardizing
pancreas histopathological stimuli on many levels from the
isolated mitochondria (Odinokova et al., 2009) to whole animal
(Mareninova et al., 2009), especially in genetically engineered
mice (Mukherjee et al., 2016). Importantly, TLCS which has
been extensively characterized in vitro, is generally preferred over
NaTC for inducing PDI-AP, especially after the identification
of the G protein-coupled bile acid receptor1 (Gpbar1) present
on the apical pole of PACs (Perides et al., 2010). Mice lacking
this receptor (Gpbar1−/−) were completely protected against
AP induced by TLCS in vivo as well as treatment with 500µM
TLCS of PACs isolated from these mice did not result in
pathophysiological Ca2+ responses, intrapancreatic trypsinogen
activation, and cell death that are normally seen in wild type
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TABLE 2 | Bile salt-induced experimental acute pancreatitis models and frequently used protocols in rodents.
Bile salt Concentration Volume Species Effect References
NaCDC 5% 2 ml/kg Rats Infusion of NaCDC followed by ligation of pancreatic duct caused
acute necrotising pancreatitis and associated lung injury
Sun et al., 2006, 2007
NaGDC 8.5, 17, or 34mM 100 µl Rats NaGDC at concentrations of 8.5-34mM caused progressive
severe but non-lethal acute pancreatitis in rats; 17 and 34mM
NaGDC infusion produced oedematous and necrotizing
pancreatitis respectively; when 200 ng EK was infused with
34mM NaGDC, necrotising pancreatitis with systemic
disturbance, and rapid lethality was produced
Terry et al., 1987; Rattner
et al., 1990; Rosen and
Tuchler, 1992
5 or 10mM 100–150 µl Rats Low concentration of NaGDC with i.v., caerulein 5 µg/kg/h
injection for 6 h caused features of moderate onset, homogeneous
moderate pancreatic injury that lasts over at least 24 h
Schmidt et al., 1992a,b
NaTDC 2, 5, or 6% 200 µl Rats 2% NaTDC infusion caused pancreatic oedema, leukocytosis, and
gradually increase of acinar cell necrosis over time until 24 h; with
higher concentration at 5 or 6%, pancreatic necrosis progressed
more rapidly
Jin et al., 2008, 2011;
Lopez-Font et al., 2010
NaTC 3, 4.5, or 5% 1 ml/kg Rats Significantly increased serum amylase, lipase, and
pro-inflammatory cytokine levels; pancreatic oedema,
vacuolisation, inflammation, hemorrhage, acinar cell and fat
necrosis; lung, liver, gastric, kidney, and brain injuries; at
concentrations of 3.0, 4.5, or 5.0% induced 72 h mortality rates of
24, 71, and 100%, respectively.
Paszt et al., 2004; Yang
et al., 2004; Leveau et al.,
2005; Dang et al., 2007;
Zhang et al., 2007; Chen
et al., 2008; de Campos
et al., 2008; Qian et al.,
2010; Xia et al., 2010; Jung
et al., 2011
2, 4, or 5% 2 ml/kg Mice 2% NaTC caused oedema, leukocyte infiltration, necrosis,
hemorrhage, and fat necrosis of the pancreas without lung injury
and lethality; higher dose of NaTC increased pulmonary BAL fluid
albumin and myeloperoxidase activity, and mortality: 10 and 60%
mortality rates at 24 h for 4 and 5% NaTC, respectively
Laukkarinen et al., 2007;
Wittel et al., 2008
TLCS 3mM 50 µl Mice TLCS 3mM infusion caused hyperamylasemia, pancreatic
oedema, inflammation, and necrosis with associated lung injury
Perides et al., 2010; Hoque
et al., 2011
5mM 50 µl Mice TLCS 5mM infusion caused hyperamylasemia, pancreatic
oedema, inflammation, and necrosis with associated lung injury
Du et al., 2018
10mM 50 µl Mice TLCS 10mM infusion caused hyperamylasemia, pancreatic
oedema, inflammation, and necrosis
Michael et al., 2013;
Louhimo et al., 2016
NaCDC, sodium chenodeoxycholate; NaGDC, sodium glycodeoxycholic acid; NaTDC, taurodeoxycholate; NaTC, sodium taurocholate; TLCS, taurolithocholic acid 3-sulfate; BAL,
bronchoalveolar lavage; EK, enterokinase; i.v., intravenous.
PACs (Perides et al., 2010). Subsequently, a variety of AP
signaling pathways, including intracellular Ca2+ overload, have
been verified on this model. The severity of this model is similar
to that of human diseases. Paradoxically, while this is an excellent
biliary AP model, it is not an ideal AP-MODS model because it
requires surgical operation.
PANCREATIC DUCT LIGATION
The pancreatic duct ligation AP (PDL-AP) model is an attempt
to experimentally recreate the “common channel,” or the
common biliopancreatic duct obstruction, postulated by Opie
(1901) as the mechanistic explanation for biliary AP following
a gallstone lodging at the Ampulla of Vater, causing bile
reflux along the pancreatic duct. Churg and Richter (1971)
first linked this model to changes in the pancreatic exocrine
function. Meyerholz and Samuel (2007) demonstrated that early
changes in the duct and PACs can be observed at 1–5 h after
ductal ligation, and 24 and 48 h were the best time points to
capture interstitial oedema and inflammatory changes of the
pancreas. Therefore, several researchers use this model in rats
to investigate the early stages of the disease pathogenesis (Lerch
et al., 1992). Studies have shown that apoptosis is the main
mechanism of cell death in the rat PDL-AP model (Walker et al.,
1992).
Recent advances (Samuel et al., 2010; Yuan et al., 2011; Le
et al., 2015) allow the application of PDL techniques in mice
(Meyerholz et al., 2008). PDL in mice causes AP with systemic
inflammation andMODS, whereas biliary duct ligation and sham
surgery does not (Samuel et al., 2010). The 4-day mortality
of mice in the PDL group was shown to be 100%, whereas
no mortality occurred in the sham operation and biliary duct
ligation groups at 15 days (Samuel et al., 2010). This model
appears to mimic gallstone obstruction-induced AP with a high
mortality, thus it could potentially be used for investigation
of the pathogenesis of severe AP and testing new therapies.
The PDL-AP model may also be suitable for studying bacterial
disorders, because biliary obstruction is associated with intestinal
bacterial overgrowth and translocation (Nieuwenhuijs et al.,
2000). The PDL-AP model has the advantage of avoiding of the
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systemic application of chemical inducers and thus undesirable
side effects, but it requires surgery, which can be challenging
particularly in small animals.
ENDOSCOPY
Since its first description in the late 1960s as a diagnostic
technique (McCune et al., 1968), endoscopic retrograde
cholangiopancreatography (ERCP) has evolved over the years
to a predominantly therapeutic tool (Cotton, 2012). Compared
with other endoscopic examinations, ERCP carries a higher
potential for complications (Andriulli et al., 2007). Post-ERCP
pancreatitis (PEP) is one of the most frequent complications
of ERCP with an incidence of 1.5–15% (Parekh et al., 2017).
However, the exact etiology as to why AP develops in some
patients is unknown, some risk factors are gender, age, physician
experience, and previous history of PEP (Radadiya et al., 2019).
There are several potential underlying mechanisms of pancreatic
injury during ERCP, including mechanical, thermal, chemical,
hydrostatic, enzymatic, and microbiologic insults (Parekh et al.,
2017).
Early in 1979, Kivisaari et al. imitated the process of ERCP by
retrograde infusion of meglumine in various concentrations for
30 s at a pressure of 20 to 50 mmHg, which proved sufficient to
produce evidence of both gross and microscopic AP in rats after
4 days such as oedema, leukocytosis, necrosis, and hemorrhage,
atrophy, and early fibrosis (Kivisaari, 1979). Since then, different
drugs, including interleukin-10, gabexate mesylate, heparin or
somatostatin, nitrate derivates or diclofenac have been tested
to reduce the incidence, and severity of PEP (He et al., 2003;
Hackert et al., 2004; Folch-Puy et al., 2006; Xiong et al., 2007;
Haciahmetoglu et al., 2008; Jin et al., 2015). He et al. described
a model of PEP based on the hypothesis that a constant,
relatively high pressure of an intraductal injection should cause
AP through disruption of the ductal integrity (He et al., 2003).
Contributing factors to the injury may include chemical toxicity
from the contrast agent, disruption of pancreatic ducts, and
even a rupture of acinar lobules as a result of forceful injection
of contrast material. Increased pressure within the pancreatic
duct has been indirectly implicated as a cause of PEP as
multiple studies have shown that placement of a pancreatic stent
following ERCP in high-risk patients reduced the incidence of
PEP (Freeman and Guda, 2004). The model was carried out
in rats by retrograde infusion of meglumine into the common
biliopancreatic duct at a high pressure (50 mmHg) thus inducing
typical histopathological changes of AP with significant increases
of serum amylase and pancreatic myeloperoxidase activity at
24 h (He et al., 2003; Xiong et al., 2007). The model mimicked
the procedure of ERCP with meglumine manifesting as edema,
inflammation, necrosis, and hemorrhage. This was consistent
with clinical PEP, which usually is relatively mild. However, the
role of applied pressure alone has been debated after Hackert
et al. (2004) and Folch-Puy et al. (2006) suggested that the
contrast itself may be playing a role in the development of PEP.
Hackert’s work showed the inflammatory reaction develops in the
pancreatic tissue when duct ligation is combined with intraductal
infusion of the contrast medium (Merriam et al., 1996; Hackert
et al., 2004).
In addition, other studies show that intraductal regulation
of pH (Noble et al., 2008) and the mechanical damage caused
by direct papillary trauma (Bozkurt et al., 2013) were found
to affect the onset of AP, and might be an important factor in
PEP. What is more, some studies show that no correlation was
detected with increasing pressure or with the use of contrast
agent (Haciahmetoglu et al., 2008). Recently, Jin et al. (2015)
and Wen et al. (2018) have developed a novel model of PEP
in mice. Their major benefit is the ability to complement
pharmacological inhibition of calcineurin along with the use
of calcineurin knockouts (Wen et al., 2018, 2020). Besides,
pancreatic injury after retrograde injection of contrast material
has also been described in larger animals such as dogs. The
frequently used PEP animal models induced by different pressure
and contrast in rodents are summarized in Table 3. These models
ultimately represent a combination of pancreatic ductal pressure
and exposure to contrast agents, both potentiating outcomes
(Figure 4).
OTHER EXPERIMENTAL AP MODELS
In recent years, pancreatic genetics has made great progress,
and the identification of mutations in genes involved in
the trypsin-dependent pathway is a significant milestone in
understanding pancreatitis onset (Mayerle et al., 2019). Genetic
experimental animal models, based on genetic techniques
(transgenic, knock out, knock in, or knock down), have
provided in vivo compelling evidence of concept of premature
intrapancreatic activation of digestive proteases (Geisz and
Sahin-Toth, 2018; Jancso et al., 2018; Sendler et al., 2018;
Geisz et al., 2019; Gui et al., 2020; Jancso and Sahin-Toth,
2020). For example, an innovative new model has recently been
developed based on the T7D23A knock-in mouse, which carries
a heterozygous p.D23A mutation in mouse cationic trypsinogen
(isoform T7) (Geisz and Sahin-Toth, 2018). T7D23A mice
develop spontaneous AP with pancreatic edema, inflammation,
and necrosis with serum amylase elevation at an early age
progressing to features of chronic pancreatitis, with clinical
relevance to hereditary pancreatitis (Geisz and Sahin-Toth,
2018). Using genetically manipulated mice, the mis-folding–
dependent, ductal, NF-κB, and cytokine signaling pathways have
also been extensively studied (Bi and Ji, 2016; Mayerle et al.,
2019).
Other AP models that have been reported in the literature
generally have not gained prominence due to their respective
limitations. Choline-deficient, 0.5% DL-ethionine supplemented
diet-induced AP was commonly used before, but it is gradually
eliminated because of some limited conditions (sex, age,
and non-specific pancreatic toxicity) and clinical relevance
(Lombardi and Rao, 1975). The immune-induced model may
represent immune factor-induced AP in humans, however, the
difficulty to set it up, its limited reproducibility and other
limitations have thus far hampered its use (Janigan et al., 1975;
Seelig and Seelig, 1975; Nevalainen et al., 1977; Nevalainen,
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TABLE 3 | Post-ERCP pancreatitis models.
Species Method Mechanisms Intervention Effectiveness References
Rats Meglumine (30%, 0.4ml) of 50 mmHg Contrast and
pressure
CP-96345 (a NK1 receptor
antagonist)
Yes He et al., 2003
Rats Ultravist (1.2 ml/kg, 5min) of 30 mmHg Contrast Heparin Yes Hackert et al., 2004
Rats Low osmolarity contrast medium
meglumine/sodium ioxaglate (Hexabrix
320) 10 µl/kg
Contrast Rosiglitazone (a PPARγ
agonist)
Yes Folch-Puy et al., 2006
Rats Meglumine (30%, 0.4ml) of 50 mmHg Contrast and
pressure
Thalidomide Yes Xiong et al., 2007
Rats Isotonic NaCl solution (0.5ml)/diluted




/ / Haciahmetoglu et al., 2008
Rats 400 µl, 50 mmHg (pH = 6, pH = 6.9, or
pH = 7.3)
Contrast pH Resiniferatoxin (a TRPV1
agonist)
Yes Noble et al., 2008
Rats Semi-dilute non-ionic contrast
agent/saline (0.5ml) of 30 mmHg
Pressure / / Bozkurt et al., 2013
Mice Iohexol, iopamidol, or normal saline







Yes Jin et al., 2015
Mice Saline with a constant hydrostatic pressure Pressure FK506 (calcineurin inhibitor),
calcineurin Aβ-deficient
mice
Yes Wen et al., 2018
NK1, neurokinin-1; PPARγ, peroxisome proliferators-activated receptor γ; TRPV1, transient receptor potential vanilloid-1.
FIGURE 4 | A schematic of experimental post-ERCP pancreatitis model. The model is induced by performing retrograde biliopancreatic ductal infusion, and the pump
is used to control rate or pressure. Intraductal pressures can be monitored using a pressure transducer.
1978; Jancar et al., 1988; Letko et al., 1990; Kanno et al.,
1992; Axelsson et al., 2008). A haemolysis-induced model has
been used to mimic AP patients under haemolysis (Saruc
et al., 2003). Dibutyltin dichloride- (Merkord and Hennighausen,
1989) and coxsackievirus- (De Palma et al., 2008, 2009) induced
models are also not very widely used due to the lack of
major clinical relevance. As for drug-induced AP (Forsmark
et al., 2016; Meczker et al., 2020), different responses to drugs
between animals and humans make this particularly difficult
to model.
IN VITRO AND EX VIVO MODELS
In vitro and Ex vivo
Besides animal models, in vitro experimental AP models primary
PACs, acinar carcinoma cell lines AR42J (rat) (Lugea et al., 2017a)
and 266-6 (mouse) (Siveke et al., 2008), and isolated pancreatic
lobules (Won et al., 2011) are often used. In 1978, Williams
et al. (1978) first developed a technique to isolate PACs and
tested the effects of supramaximal doses of CCK and caerulein.
Mouse PACs express CCK receptors, of both high and low
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affinity, which can be activated by low and high concentrations of
caerulein/CCK further activating intracellular signaling pathways
(summarized in Supplementary Table 1) (Williams, 2001, 2002).
Low physiological doses of CCK (or caerulein) bind to
high-affinity CCK receptors and mediate pancreatic secretion
and growth, whereas high or supra-physiological doses (a
concentration exceeding the dose at which maximal amylase
secretion is observed) bind to low affinity receptors and inhibit
pancreatic secretion, resulting in zymogen activation and PAC
injury (Williams, 2001, 2002; Saluja et al., 2007). Grady et al.
(1998) and Saluja et al. (1999) reported that no enzyme activation
occurred at CCK concentrations below 10−10 M, whereas
supramaximal stimulation by CCK (concentration >10−10 M)
results in zymogen activation and PACs injury. Although CCK
receptors are abundant in mouse PACs, it is controversial
whether CCK receptors exist in human PACs. In 2001, Ji et al.
reported that CCK does not cause any changes in human PAC
function as was assessed by Ca2+ release, amylase secretion,
and ERK phosphorylation (Ji et al., 2001). Subsequently, some
researchers have reported that CCK can cause Ca2+ oscillation
and stimulate enzyme secretion in human PACs (Murphy et al.,
2008; Wen et al., 2015; Mukherjee et al., 2016; Lugea et al.,
2017a,b; Waldron et al., 2019). We have summarized some key
information about these studies in Supplementary Table 2.
Subsequent studies carried out in animal models that simulate
the human disease suggested that the PACs were the initial site
of morphological damage (Lerch et al., 1992). The latest reviews
summarizes the effects of CCK on PACs (Williams, 2019) and
early acinar events in the pathogenesis of AP (Saluja et al.,
2019). The most notable limitation of primary PACs is their
in vitro viability is relatively short and thus they cannot be
used for long-term experiments or subculturing, an advantage
that acinar carcinoma cell lines can offer. However, one must
be note that while acinar carcinoma cell lines retain some
phenotypes of primary PACs (i.e., containing a multitude of
digestive enzyme mRNAs and responding to CCK), they may
have changed enzyme activities and receptors or start to express
other specific receptors.
In contrast to the methods that yield single PACs, isolation
of the pancreatic lobules (Won et al., 2011; Gryshchenko et al.,
2016) offers a more physiological ex vivomodel to study signaling
events in the exocrine pancreatic tissue. Since the lobules
preserve most of the spatial characteristics of the intact acini
and contain non-PACs such as such as pancreatic stellate cells
(PSCs), they can be used to study the role of interactions between
different cell types in the development AP. Lobules of size up to 1
mm3 may bemanually cut from a saline-injected mouse pancreas
(Won et al., 2011), whereas much smaller lobules can be isolated
from the organ using amodified protocol of collagenase digestion
(Ferdek et al., 2016; Gryshchenko et al., 2016; Jakubowska et al.,
2016). Loading the lobules with fluorescent Ca2+ indicators has
made it possible to investigate how different populations of
pancreatic cells orchestrate physiological and pathological Ca2+
signals (Won et al., 2011; Ferdek et al., 2016; Gryshchenko et al.,
2016; Jakubowska et al., 2016). This model was successfully used
to show that Ca2+ signal evoked in cells of one phenotype
is not transmitted to different cells (Won et al., 2011). Using
the multiphoton imaging and Fluo-4 AM Ca2+ indicator, Won
et al. (2011) confirmed that, even in a close vicinity, different
cell populations may form entirely separated signaling units.
Gryshchenko et al. (2016) later confirmed that blockade of
the bradykinin B2 receptor with antagonist WIN64338 reduces
PAC necrosis in the lobules, elicited by common toxins of the
pancreas: ethanol, FAEE, or bile acids. Further analyses of the
lobular signaling pointed toward more toxic effects of certain
bile acids in PSCs than in PACs (Ferdek et al., 2016): this
study showed that sodium bile salts, cholate, and taurocholate,
elicit noxious Ca2+ signals in PSCs, and induce considerable
levels of PSC necrosis in the lobules, whereas TLCS mainly
induces pathological Ca2+ signals and necrotic cell death in
PACs. Importantly, development of the real-time method to
simultaneously record Ca2+ signals (Fura-2 indicator) and nitric
oxide signals (DAF-2 fluorescent dye) in the lobules, confirmed
the interplay between these signaling pathways solely in PSCs,
and their absence in PACs, in response to stimulation of
the lobules with bradykinin (Jakubowska et al., 2016). PSCs
generated Ca2+ responses in form of Ca2+ oscillations or
transients, accompanied by the intracellular increase in nitric
oxide, in response to bradykinin, cholate, and taurocholate, but
not TLCS. In a mouse model of alcohol-induced AP, lobular PSCs
were desensitized to the signaling mediated by bradykinin B2
receptor, but sensitized to the signaling mediated by B1 receptor
(Gryshchenko et al., 2018). This sensitivity switch is a general
feature of inflammatory diseases (Petho and Reeh, 2012). The
aforementioned studies demonstrate that pancreatic lobules are a
valuable alternative to single cell type in vitromodels, particularly
in the early stages of investigation. This model could potentially
be developed further to investigate signaling events in pancreatic
lobules of human origin.
Normal exocrine functions of the pancreas center around
pancreatic juice secretion (Hegyi et al., 2011; Hegyi and Petersen,
2013). In order to form this enzyme-rich alkaline fluid, cells of the
acinar compartment cooperate with the epithelia of pancreatic
ducts. PACs secrete enzymes capable of hydrolysis of the proteins,
polysaccharides, lipids, and nucleic acids, whereas pancreatic
ductal cells (PDCs) release isotonic solution rich in bicarbonate
that aids the transport of the enzymes into the duodenum and
neutralizes the gastric acid (Lee et al., 2012). Not only PACs but
also PDCs play their roles in the development of AP. For example,
obstruction of the pancreatic duct can influence the trafficking of
PAC membrane (Lerch et al., 1995a); and inducers of AP, such
as bile acids, reduce the intracellular pH of PDCs (Venglovecz
et al., 2008). The technique of PAC isolation via enzymatic
digestion of the pancreas has been widely applied in the past few
decades to study the physiology and pathophysiology of these
cells (Thorn et al., 1993). Similarly, the protocol of pancreatic
duct isolation was initially developed in the 80’s and it is also
based on enzymatic digestion of the tissue (Argent et al., 1986).
However, this enzymatic processing could affect the physiology of
ductal epithelia and thus may require additional steps facilitating
ductal regeneration, which extends and complicates the entire
procedure (Gal et al., 2019). In order to address this limitation,
Gal et al. recently proposed a novel in situ approach that aims to
preserve the physiological environment and the ductal structure









































Invasive Advantages Disadvantages References
Caerulein (rats/mice) Scorpion bites or
organophosphate
insecticides
Yes Adjustable severity from
oedematous to necrotising
pancreatitis by number of
caerulein (normally 50
µg/kg) injections
No Yes No No • Injection only required so
easy to perform
• Large wealth of
pre-clinical data exists
using model
• Rare clinical parallel Lampel and Kern, 1977;
Niederau et al., 1985; Saluja
et al., 2007
L-arginine (rats/mice) Limited Yes Adjustable severity from
mild, moderate to severe
necrotizing pancreatitis by




Yes Yes No • Injection only required so
easy to perform
• Adjustable mortality useful
for severity assessment





Tashiro et al., 2001; Hegyi





Alcoholic excess Yes Moderate to severe
pancreatitis
No Yes No No • Easy to perform
• Moderate
clinical relevance
• Limited ability to
modulate in terms
of severity
Pandol et al., 2003; Perides
et al., 2005; Lugea et al.,
2010
Ethonal/FFA (mice) Alcoholic excess Yes Moderate to severe
pancreatitis
Yes Yes Yes No • Injection only required so
easy to perform
• Strong clinical relevance
• Potential for Systemic
toxicity
• Difficult to modulate
potential for mortality
Huang et al., 2014, 2017;




Biliary Yes Moderate to severe
pancreatitis depending on




Yes Yes Yes • Strong clinical relevance
• Adjustable mortality useful
for severity assessment
within the same model
• Requires micro-surgical
training
• Potential for systemic
toxicity and detergent
effects of the bile salts
Schmidt et al., 1992a,b;
Laukkarinen et al., 2007;






No Moderate to severe
pancreatitis
Yes Yes No Yes • Strong clinical relevance




Lerch et al., 1993; Mooren








No Mild to moderate
pancreatitis
No No No Yes • Strong clinical relevance






He et al., 2003; Hackert
et al., 2004; Xiong et al.,
2007; Noble et al., 2008; Jin
et al., 2015; Radadiya et al.,
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of the mouse pancreatic tissue (Gal et al., 2019). By injecting
(post-mortem) low melting point agarose into the pancreatic
duct and a subsequent cooling of the whole organ, agarose settles
in the pancreatic ductal system and helps to maintain its three
dimensional architecture. Importantly, by using a vibratome,
slices of the agarose-reinforced pancreatic tissue can be cut and
used for the subsequent analyses, such as measurements of Ca2+
signals in real-time (Gal et al., 2019). The authors showed that
treatment of PDCs with 1mM chenodeoxycholic acid evokes
robust transient increases in intracellular Ca2+ and triggers cell
movement that precedes the development of Ca2+ responses in
these cells (Gal et al., 2019). This new in situmodel is likely to be
a very useful tool for testing the effects of the common inducers of
AP on PDCs and may add to our knowledge about the roles these
cells play in pancreatic pathologies (Supplementary Table 3).
While models of the isolated mouse pancreatic ducts offer
means for studying the functional characteristics of the epithelial
surfaces, they are not designed to investigate ducts as structures
that form fluid-filled cavities. This potential limitation can be
addressed by employing pancreatic ductal organoid cultures (Boj
et al., 2015) for analyzing ion secretion (Molnar et al., 2020).
Ductal epithelia can be grown as organoids with a hollow center
(the lumen), which preserves the planar cell polarity and the
physiological pattern of the membrane transporters. In order to
measure real time changes in the intraluminal pH, concentration
of chloride anions or the processes of bicarbonate secretion, the
lumen can be injected with an appropriate fluorescent indicator
(Molnar et al., 2020). In the near future, organoid cultures
might aid the preclinical studies on the disrupted physiological
processes that drive the development of pancreatic disorders.
COMPARISON OF COMMONLY USED
MODELS IN RODENTS
Not all animal models of AP developed in the past are equally
popular among researchers today. It is very difficult to compare
models of AP due to the differences between animals and
strains used, the microbiome and the environmental cues, or
reagents/experimental conditions. There is a growing trend
toward the use of PDI-AP and PDL-AP models particularly
in genetic studies. L-arginine and other amino acids-induced
animal models in rodents are now undergoing thorough
investigation. Current animal models of AP are classified for
severity on the basis of an inducer/etiology that causes pancreatic
necrosis (Lerch and Gorelick, 2013). In contrast, the presence of
necrosis in the human disease does not automatically translate
into poorer outcomes. This is a significant limitation since
severity in human AP is unrelated to pancreatic necrosis or
etiology, with the exception of hypertriglyceridemia-associated
TABLE 5 | Pharmacological therapy tested in pre-clinical AP models.
Agent Target Effect in vitro Model Pancreas System References
Caffeine IP3R Inhibitor Mouse PACs TLCS-AP, CER-AP, FAEE-AP Yes No Huang et al., 2017
GSK-7975A ORAI1 Inhibitor Human PACs, Mouse PACs TLCS-AP, CER-AP, FAEE-AP Yes Yes Wen et al., 2015
CM4620 ORAI1 Inhibitor Human PACs, Mouse PACs TLCS-AP, FAEE-AP Yes Yes Wen et al., 2015
DEB025 Cyclophilins Inhibitor Human PACs, Mouse PACs TLCS-AP, CER-AP Yes Yes Mukherjee et al.,
2016
TRO40303 Cyclophilins Inhibitor Human PACs, Mouse PACs TLCS-AP, CER-AP Yes Yes Mukherjee et al.,
2016
Vitamin K3 Autophagy Inhibitor NA CER-AP Yes NA Chinzei et al.,
2011
CYT387 TBK1/IKKε/JAK Inhibitor PDACs NA Yes NA Yang et al., 2016
Trehalose Autophagy Enhancer NA ARG-AP Yes NA Biczo et al., 2018
CID755673 PKD & NF-κB Inhibitor Rat PACs CER-AP Yes NA Yuan et al., 2017
CRT0066101 PKD & NF-κB Inhibitor Rat PACs CER-AP Yes NA Yuan et al., 2017
IRS954 TLR9 Antagonist NA TLCS-AP, CER-AP Yes NA Hoque et al., 2011
Cl-amidine NETosis Inhibitor NA NaTC-AP Yes Yes Madhi et al., 2019
Chloroquine NETosis Inhibitor NA ARG-AP, CDE-AP Yes Yes Murthy et al., 2019
Infliximab TNF-α Antibody NA NaTC-AP Yes NA Tekin et al., 2015
Infliximab TNF-α Antibody Rat peritoneal macrophages NaTC-AP Yes Yes Luo et al., 2010
Somatostatin Somatostatin receptor Agonist NA PDL-AP Yes NA Baxter et al., 1985
Octreotide Somatostatin receptor Agonist NA NaTC-AP Yes Yes Huang et al., 2012
Ulinastatin Serine protease Inhibitor NA NaTC-AP Yes Yes Pan et al., 2017
GSK180 Kynurenine-3-monooxygenase Inhibitor NA NaTC & CER-AP Yes Yes Mole et al., 2016
NA, not available; IP3R, inositol trisphosphate receptor; ORAI1, calcium release-activated calcium modulator 1; TBK1, TANK-binding kinase 1; IKKε, inhibitor of kappa B kinase epsilon;
JAK, Janus kinase; PKD, protein kinase D; NF-κB, nuclear factor kappa-B; TLR9, Toll-like receptor 9; TNF-α, tumor necrosis factor alpha; PACs, pancreatic acinar cells; PDAC, pancreatic
ductal adenocarcinoma; CER-AP, caerulein-induced acute pancreatitis; CDE-AP, CDE-diet induced acute pancreatitis; NaTC-AP, sodium taurocholate-induced acute pancreatitis;
ARG-AP, L-arginine-induced acute pancreatitis; TLCS-AP, taurolithocholic acid 3-sulfate induced acute pancreatitis; PDL-AP, pancreatic duct ligation-induced acute pancreatitis;
FAEE-AP, fatty acid ethyl ester-induced acute pancreatitis.
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TABLE 6 | Pharmacological therapy for AP in currently clinical trials.
Agent Conditions Status Number Site Locations Phase NCT Number
CM4620 Acute pancreatitis Recruiting 42 Single United States Phase 1; Phase 2 NCT04195347
Acute pancreatitis; SIRS Completed 21 Multiple United States Phase 2 NCT03401190
Infliximab Acute pancreatitis Recruiting 290 Single United Kingdom Phase 2 NCT03684278
Somatostatin Post-ERCP pancreatitis Completed 300 Single Greece NA NCT00222092
Octreotide Post-ERCP pancreatitis Completed 300 Single Greece NA NCT00222092
Ulinastatin Acute pancreatitis Suspended 252 Multiple China Phase 4 NCT01132521
CytoSorb Acute pancreatitis; SIRS Unknown 30 NA NA Phase 4 NCT03082469
NA, not available; SIRS, systemic inflammatory response syndrome; ERCP, endoscopic retrograde cholangiopancreatography.
AP. The comparison of currently used models is summarized in
Table 4.
EXPERIMENTAL AP MODELS IN
TRANSLATIONAL RESEARCH
In recent years, there has been an increasing number of
medical studies in the pancreatic field (Mukherjee et al.,
2019). Animal models play here an indispensable role by
bridging basic science with translational research. Animal
models allow detailed investigation of the crucial events in
the pathophysiology of the disease and are thus important in
establishing causality. The names, targets, models used and
whether they are effective for system damage caused by AP are
summarized in Table 5. However, it pays to remember that even
very promising findings made on animal models, particularly
those regarding novel therapeutic agents, may not always show
efficacy in clinical trials (Moggia et al., 2017). The latter caveat
may be improved by understanding critical thresholds for
cellular events (Barreto et al., 2020) and assessing potential
pharmacological therapeutics in different models including in
vivo and in vitro with multiple biochemical, immunological and
histopathological indices, before designing appropriate clinical
trials. Some drugs with good curative effect on animal models
that successfully transformed into clinical trials are shown in
Table 6. It is also crucial to understand that in animal studies
the therapeutic agent is most often administered prophylactically
i.e., before or simultaneously with the administration of AP.
However, in majority of clinical trials treatment can only
be instituted after the onset of symptoms. Hence the main
focus of animal studies has been toward understanding the
mechanistic pathways involved in the pathogenesis of disease.
To date, there is no perfect model that shares all typical
characteristics of human AP and the failure of anti-inflammatory
(Kingsnorth et al., 1995; Kingsnorth, 1996; Johnson et al.,
2001), antioxidants (Siriwardena et al., 2007) and antibiotics
(Dellinger et al., 2007; Bai et al., 2008; Garcia-Barrasa et al.,
2009) to ameliorate AP in human clinical trials, despite their
success in animal models, demonstrates well the difficulties
in translating the results from animal studies to the clinic.
Therefore, there is a long way to go from animal experiment
to clinical transformation. Considering these factors it is vital
that looking to the future we embrace advances in cellular
technologies and in particular human organoids that may
provide improved and more representative models (Kim et al.,
2020).
SUMMARY
Animal models of AP, whether they are invasive or non-invasive,
carried out on large or small animals, wild type or transgenic
animals, have provided and continue to provide key insights
into the etiology and pathogenesis of AP as well as aid the
identification of new therapeutic targets or biomarkers useful
for the treatment of the disease. They remain an indispensable
tool for the study of AP. As our understanding of the disease
continues to improve, it is likely that new and more relevant
models will be developed in the near future.
DATA AVAILABILITY STATEMENT
The raw data supporting the conclusions of this article will be
made available by the authors, without undue reservation.
AUTHOR CONTRIBUTIONS
XY and LY performed literature search and drafted the
manuscript. PF, MJ, and RM reviewed and critically
revised the manuscript. XF and QX obtained funding
and had important intelligent input. WH obtained
funding, conceptualized the study, supervised students,
drafted, and critically revised the manuscript. All authors
have read and agreed to the published version of
the manuscript.
FUNDING
This research was funded by National Nature Science Foundation
of China (Grant No. 81973632, WH; Grant No. 81774120, QX;
Grant No. 81970561, XF) and the Ministry of Science and
Technology of China (Grant No. 2018ZX09201018-005, XF);
the National Science Center of Poland (Narodowe Centrum
Frontiers in Physiology | www.frontiersin.org 15 December 2020 | Volume 11 | Article 614591
Yang et al. Experimental Acute Pancreatitis Models
Nauki, NCN, No. 2019/33/B/NZ3/02578, PF), HOMING
Programme of the Foundation for Polish Science (Fundacja na
rzecz Nauki Polskiej, FNP, No. HOMING/2017-4/31, PF; No,
HOMING/2017-3/23, MJ), co-financed by the European Union
under the European Regional Development Fund.
SUPPLEMENTARY MATERIAL




Adler, G., Gerhards, G., Schick, J., Rohr, G., and Kern, H. F. (1983). Effects of in vivo
cholinergic stimulation of rat exocrine pancreas.Am. J. Physiol. 244, G623–629.
doi: 10.1152/ajpgi.1983.244.6.G623
Anastasi, A., Erspamer, V., and Endean, R. (1968). Isolation and amino acid
sequence of caerulein, the active decapeptide of the skin of hyla caerulea. Arch.
Biochem. Biophys. 125, 57–68. doi: 10.1016/0003-9861(68)90638-3
Andriulli, A., Loperfido, S., Napolitano, G., Niro, G., Valvano, M. R.,
Spirito, F., et al. (2007). Incidence rates of post-ERCP complications: a
systematic survey of prospective studies. Am. J. Gastroenterol. 102, 1781–1788.
doi: 10.1111/j.1572-0241.2007.01279.x
Andrzejewska, A., Dlugosz, J. W., and Jurkowska, G. (1998). The effect
of antecedent acute ethanol ingestion on the pancreas ultrastructure
in taurocholate pancreatitis in rats. Exp. Mol. Pathol. 65, 64–77.
doi: 10.1006/exmp.1998.2226
Argent, B. E., Arkle, S., Cullen, M. J., and Green, R. (1986). Morphological,
biochemical and secretory studies on rat pancreatic ducts maintained in tissue
culture. Q. J. Exp. Physiol. 71, 633–648. doi: 10.1113/expphysiol.1986.sp003023
Axelsson, J., Norrman, G., Malmstrom, A., Westrom, B., and Andersson, R.
(2008). Initiation of acute pancreatitis by heparan sulphate in the rat. Scand.
J. Gastroenterol. 43, 480–489. doi: 10.1080/00365520701733814
Bai, Y., Gao, J., Zou, D. W., and Li, Z. S. (2008). Prophylactic antibiotics
cannot reduce infected pancreatic necrosis and mortality in acute necrotizing
pancreatitis: evidence from a meta-analysis of randomized controlled trials.
Am. J. Gastroenterol. 103, 104–110. doi: 10.1111/j.1572-0241.2007.01575.x
Barreto, S. G., Habtezion, A., Gukovskaya, A., Lugea, A., Jeon, C., Yadav,
D., et al. (2020). Critical thresholds: key to unlocking the door to
the prevention and specific treatments for acute pancreatitis. Gut 1–10.
doi: 10.1136/gutjnl-2020-322163
Baxter, J. N., Jenkins, S. A., Day, D.W., Roberts, N. B., Cowell, D. C., Mackie, C. R.,
et al. (1985). Effects of somatostatin and a long-acting somatostatin analogue
on the prevention and treatment of experimentally induced acute pancreatitis
in the rat. Br. J. Surg. 72, 382–385. doi: 10.1002/bjs.1800720516
Bernard, C. (1856). Lecons de Physiologie Experimentale. Vol 2. Paris: Bailliere.
Bertola, A., Mathews, S., Ki, S. H., Wang, H., and Gao, B. (2013). Mouse model of
chronic and binge ethanol feeding (the NIAAAmodel).Nat. Protoc. 8, 627–637.
doi: 10.1038/nprot.2013.032
Bi, Y., and Ji, B. (2016). Spontaneous Pancreatitis in Genetically Modified
Animal Strains. Pancreapedia: Exocrine Pancreas Knowledge Base.
doi: 10.3998/panc.2016.8
Biczo, G., Hegyi, P., Dosa, S., Balla, Z., Venglovecz, V., Ivanyi, B.,
et al. (2011a). Aliphatic, but not imidazole, basic amino acids cause
severe acute necrotizing pancreatitis in rats. Pancreas 40, 486–487.
doi: 10.1097/MPA.0b013e31820a598a
Biczo, G., Hegyi, P., Dosa, S., Shalbuyeva, N., Berczi, S., Sinervirta, R., et al. (2011b).
The crucial role of early mitochondrial injury in L-lysine-induced acute
pancreatitis. Antioxid. Redox Signal. 15, 2669–2681. doi: 10.1089/ars.2011.4065
Biczo, G., Hegyi, P., Sinervirta, R., Berczi, S., Dosa, S., Siska, A.,
et al. (2010). Characterization of polyamine homeostasis in l-
ornithine-induced acute pancreatitis in rats. Pancreas 39, 1047–1056.
doi: 10.1097/MPA.0b013e3181d3cdf0
Biczo, G., Vegh, E. T., Shalbueva, N., Mareninova, O. A., Elperin, J., Lotshaw, E.,
et al. (2018). Mitochondrial dysfunction, through impaired autophagy,
leads to endoplasmic reticulum stress, deregulated lipid metabolism,
and pancreatitis in animal models. Gastroenterology 154, 689–703.
doi: 10.1053/j.gastro.2017.10.012
Bieger, W., Martin-Achard, A., Bassler, M., and Kern, H. F. (1976a). Studies on
intracellular transport of secretory proteins in the rat exocrine pancreas. IV.
Stimulation by in vivo infusion of caerulein. Cell Tissue Res. 165, 435–453.
doi: 10.1007/BF00224474
Bieger,W., Seybold, J., and Kern, H. F. (1976b). Studies on intracellular transport of
secretory proteins in the rat exocrine pancreas. V. Kinetic studies on accelerated
transport following caerulein infusion in vivo. Cell Tissue Res. 170, 203–219.
doi: 10.1007/BF00224299
Boj, S. F., Hwang, C. I., Baker, L. A., Chio, I. I., Engle, D. D., Corbo, V., et al.
(2015). Organoid models of human and mouse ductal pancreatic cancer. Cell
160, 324–338. doi: 10.1016/j.cell.2014.12.021
Bozkurt, S., Guner, A., Kadioglu, H., Kece, C., Reis, E., and Coskun, H. (2013).
The effects of different mechanisms on the development of post-ERCP
pancreatitis in an ERCP model in rats. Turk. J. Gastroenterol. 24, 469–475.
doi: 10.4318/tjg.2013.0654
Cederbaum, A. I. (2012). Alcohol metabolism. Clin. Liver Dis. 16, 667–685.
doi: 10.1016/j.cld.2012.08.002
Chao, K. C., Chao, K. F., Chuang, C. C., and Liu, S. H. (2006). Blockade of
interleukin 6 accelerates acinar cell apoptosis and attenuates experimental acute
pancreatitis in vivo. Br. J. Surg. 93, 332–338. doi: 10.1002/bjs.5251
Chen, X., Li, S. L., Wu, T., and Liu, J. D. (2008). Proteasome inhibitor
ameliorates severe acute pancreatitis and associated lung injury of rats. World
J. Gastroenterol. 14, 3249–3253. doi: 10.3748/wjg.14.3249
Chinzei, R., Masuda, A., Nishiumi, S., Nishida, M., Onoyama, M., Sanuki, T.,
et al. (2011). Vitamin K3 attenuates cerulein-induced acute pancreatitis
through inhibition of the autophagic pathway. Pancreas 40, 84–94.
doi: 10.1097/MPA.0b013e3181f69fc9
Churg, A., and Richter, W. R. (1971). Early changes in the exocrine pancreas
of the dog and rat after ligation of the pancreatic duct. A light and electron
microscopic study. Am. J. Pathol. 63, 521–546.
Clemens, D. L., Schneider, K. J., Arkfeld, C. K., Grode, J. R., Wells, M.
A., and Singh, S. (2016). Alcoholic pancreatitis: new insights into the
pathogenesis and treatment. World J. Gastrointest. Pathophysiol. 7, 48–58.
doi: 10.4291/wjgp.v7.i1.48
Cotton, P. B. (2012). Endoscopic retrograde cholangiopancreatography:
maximizing benefits and minimizing risks. Gastrointest. Endosc. Clin. N.
Am. 22, 587–599. doi: 10.1016/j.giec.2012.05.002
Criddle, D. N., Booth, D. M., Mukherjee, R., McLaughlin, E., Green, G. M.,
Sutton, R., et al. (2009). Cholecystokinin-58 and cholecystokinin-8 exhibit
similar actions on calcium signaling, zymogen secretion, and cell fate in
murine pancreatic acinar cells. Am. J. Physiol. Gastrointest. Liver Physiol. 297,
G1085–1092. doi: 10.1152/ajpgi.00119.2009
Criddle, D. N., Murphy, J., Fistetto, G., Barrow, S., Tepikin, A. V., Neoptolemos,
J. P., et al. (2006). Fatty acid ethyl esters cause pancreatic calcium toxicity via
inositol trisphosphate receptors and loss of ATP synthesis. Gastroenterology
130, 781–793. doi: 10.1053/j.gastro.2005.12.031
Czako, L., Takacs, T., Varga, I. S., Hai, D. Q., Tiszlavicz, L., Hegyi, P., et al.
(2000). The pathogenesis of L-arginine-induced acute necrotizing pancreatitis:
inflammatory mediators and endogenous cholecystokinin. J. Physiol. Paris 94,
43–50. doi: 10.1016/S0928-4257(99)00104-7
Czako, L., Takacs, T., Varga, I. S., Tiszlavicz, L., Hai, D. Q., Hegyi, P., et al.
(1998). Involvement of oxygen-derived free radicals in L-arginine-induced
acute pancreatitis. Dig. Dis. Sci. 43, 1770–1777. doi: 10.1023/A:10188398
21176
Dang, S. C., Zhang, J. X., Qu, J. G., Wang, X. Q., and Fan, X. (2007).
Ligustrazine alleviates gastric mucosal injury in a rat model of acute
necrotizing pancreatitis. Hepatobiliary Pancreat Dis. Int. 6, 213–218.
doi: 10.1111/j.1523-5378.2007.00489.x
Dawra, R., and Saluja, A. K. (2012). L-arginine-Induced Experimental
Acute Pancreatitis. Pancreapedia: Exocrine Pancreas Knowledge Base.
doi: 10.3998/panc.2012.6
Frontiers in Physiology | www.frontiersin.org 16 December 2020 | Volume 11 | Article 614591
Yang et al. Experimental Acute Pancreatitis Models
Dawra, R., Sharif, R., Phillips, P., Dudeja, V., Dhaulakhandi, D., and Saluja, A. K.
(2007). Development of a new mouse model of acute pancreatitis induced by
administration of L-arginine. Am. J. Physiol. Gastrointest. Liver Physiol. 292,
G1009–1018. doi: 10.1152/ajpgi.00167.2006
de Campos, T., Deree, J., Martins, J. O., Loomis, W. H., Shenvi, E., Putnam,
J. G., et al. (2008). Pentoxifylline attenuates pulmonary inflammation and
neutrophil activation in experimental acute pancreatitis. Pancreas 37, 42–49.
doi: 10.1097/MPA.0b013e3181612d19
De Palma, A. M., Thibaut, H. J., Li, S., Van Aelst, I., Dillen, C., Swinnen, M., et al.
(2009). Inflammatory rather than infectious insults play a role in exocrine tissue
damage in a mouse model for coxsackievirus B4-induced pancreatitis. J. Pathol.
217, 633–641. doi: 10.1002/path.2501
De Palma, A. M., Verbeken, E., Van Aelst, I., Van den Steen, P. E., Opdenakker, G.,
and Neyts, J. (2008). Increased gelatinase B/matrix metalloproteinase 9 (MMP-
9) activity in a murine model of acute coxsackievirus B4-induced pancreatitis.
Virology 382, 20–27. doi: 10.1016/j.virol.2008.08.046
Dellinger, E. P., Tellado, J. M., Soto, N. E., Ashley, S. W., Barie, P. S., Dugernier,
T., et al. (2007). Early antibiotic treatment for severe acute necrotizing
pancreatitis: a randomized, double-blind, placebo-controlled study. Ann. Surg.
245, 674–683. doi: 10.1097/01.sla.0000250414.09255.84
Dressel, T. D., Goodale, R. L, Jr., Zweber, B., and Borner, J. W. (1982).
The effect of atropine and duct decompression on the evolution of
diazinon-induced acute canine pancreatitis. Ann. Surg. 195, 424–434.
doi: 10.1097/00000658-198204000-00008
Du, D., Yao, L., Zhang, R., Shi, N., Shen, Y., Yang, X., et al. (2018). Protective
effects of flavonoids from Coreopsis tinctoria Nutt. on experimental acute
pancreatitis via Nrf-2/ARE-mediated antioxidant pathways. J. Ethnopharmacol.
224, 261–272. doi: 10.1016/j.jep.2018.06.003
Ferdek, P. E., Jakubowska, M. A., Gerasimenko, J. V., Gerasimenko, O. V., and
Petersen, O. H. (2016). Bile acids induce necrosis in pancreatic stellate cells
dependent on calcium entry and sodium-driven bile uptake. J. Physiol. 594,
6147–6164. doi: 10.1113/JP272774
Foitzik, T., Fernandez-del Castillo, C., Rattner, D. W., Klar, E., and
Warshaw, A. L. (1995). Alcohol selectively impairs oxygenation of the
pancreas. Arch. Surg. 130, 357–360. doi: 10.1001/archsurg.1995.01430040
019001
Foitzik, T., Hotz, H. G., Hot, B., Kirchengast, M., and Buhr, H. J.
(1998). Endothelin-1 mediates the alcohol-induced reduction of
pancreatic capillary blood flow. J. Gastrointest. Surg. 2, 379–384.
doi: 10.1016/S1091-255X(98)80078-4
Foitzik, T., Lewandrowski, K. B., Fernandez-del Castillo, C., Rattner, D.
W., Klar, E., and Warshaw, A. L. (1994). Exocrine hyperstimulation
but not pancreatic duct obstruction increases the susceptibility
to alcohol-related pancreatic injury. Arch. Surg. 129, 1081–1085.
doi: 10.1001/archsurg.1994.01420340095018
Folch-Puy, E., Granell, S., Iovanna, J. L., Barthet, M., and Closa, D. (2006).
Peroxisome proliferator-activated receptor gamma agonist reduces the severity
of post-ERCP pancreatitis in rats. World J. Gastroenterol. 12, 6458–6463.
doi: 10.3748/wjg.v12.i40.6458
Forsmark, C. E., Vege, S. S., and Wilcox, C. M. (2016). Acute pancreatitis. N. Engl.
J. Med. 375, 1972–1981. doi: 10.1056/NEJMra1505202
Freeman, M. L., and Guda, N. M. (2004). Prevention of post-ERCP
pancreatitis: a comprehensive review. Gastrointest. Endosc. 59, 845–864.
doi: 10.1016/S0016-5107(04)00353-0
Friedman, H. S., Lowery, R., Shaughnessy, E., and Scorza, J. (1983). The effects of
ethanol on pancreatic blood flow in awake and anesthetized dogs. Proc. Soc.
Exp. Biol. Med. 174, 377–382. doi: 10.3181/00379727-174-41751
Gal, E., Dolensek, J., Stozer, A., Pohorec, V., Ebert, A., and Venglovecz, V. (2019).
A novel in situ approach to studying pancreatic ducts in mice. Front. Physiol.
10:938. doi: 10.3389/fphys.2019.00938
Gallagher, S., Sankaran, H., and Williams, J. A. (1981). Mechanism of scorpion
toxin-induced enzyme secretion in rat pancreas. Gastroenterology 80, 970–973.
doi: 10.1016/0016-5085(81)90067-6
Garcia-Barrasa, A., Borobia, F. G., Pallares, R., Jorba, R., Poves, I., Busquets, J., et al.
(2009). A double-blind, placebo-controlled trial of ciprofloxacin prophylaxis in
patients with acute necrotizing pancreatitis. J. Gastrointest. Surg. 13, 768–774.
doi: 10.1007/s11605-008-0773-7
Geisz, A., Jancso, Z., Nemeth, B. C., Hegyi, E., and Sahin-Toth, M. (2019). Natural
single-nucleotide deletion in chymotrypsinogen C gene increases severity of
secretagogue-induced pancreatitis in C57BL/6 mice. JCI Insight 4:e129717.
doi: 10.1172/jci.insight.129717
Geisz, A., and Sahin-Toth, M. (2018). A preclinical model of chronic
pancreatitis driven by trypsinogen autoactivation. Nat. Commun. 9:5033.
doi: 10.1038/s41467-018-07347-y
Gorelick, F. S., and Lerch, M. M. (2017). Do animal models of acute pancreatitis
reproduce human disease? Cell Mol. Gastroenterol. Hepatol. 4, 251–262.
doi: 10.1016/j.jcmgh.2017.05.007
Grady, T., Mah’Moud, M., Otani, T., Rhee, S., Lerch, M. M., and Gorelick,
F. S. (1998). Zymogen proteolysis within the pancreatic acinar cell
is associated with cellular injury. Am. J. Physiol. 275, G1010–1017.
doi: 10.1152/ajpgi.1998.275.5.G1010
Gryshchenko, O., Gerasimenko, J. V., Gerasimenko, O. V., and Petersen, O.
H. (2016). Ca2+ signals mediated by bradykinin type 2 receptors in normal
pancreatic stellate cells can be inhibited by specific Ca2+ channel blockade. J.
Physiol. 594, 281–293. doi: 10.1113/JP271468
Gryshchenko, O., Gerasimenko, J. V., Peng, S., Gerasimenko, O. V., and
Petersen, O. H. (2018). Calcium signalling in the acinar environment of the
exocrine pancreas: physiology and pathophysiology. J. Physiol. 596, 2663–2678.
doi: 10.1113/JP275395
Gui, F., Zhang, Y., Wan, J., Zhan, X., Yao, Y., Li, Y., et al. (2020). Trypsin activity
governs increased susceptibility to pancreatitis in mice expressing human
PRSS1R122H. J. Clin. Invest. 130, 189–202. doi: 10.1172/JCI130172
Gukovskaya, A. S., Mouria, M., Gukovsky, I., Reyes, C. N., Kasho, V. N.,
Faller, L. D., et al. (2002). Ethanol metabolism and transcription factor
activation in pancreatic acinar cells in rats. Gastroenterology 122, 106–118.
doi: 10.1053/gast.2002.30302
Haciahmetoglu, T., Ertekin, C., Dolay, K., Yanar, F., Yanar, H., and Kapran, Y.
(2008). The effects of contrast agent and intraductal pressure changes on the
development of pancreatitis in an ERCPmodel in rats. Langenbecks. Arch. Surg.
393, 367–372. doi: 10.1007/s00423-007-0214-1
Hackert, T., Werner, J., Gebhard, M. M., and Klar, E. (2004). Effects of heparin in
experimental models of acute pancreatitis and post-ERCP pancreatitis. Surgery
135, 131–138. doi: 10.1016/j.surg.2003.08.001
Hardman, J., Shields, C., Schofield, D., McMahon, R., Redmond, H. P., and
Siriwardena, A. K. (2005). Intravenous antioxidant modulation of end-organ
damage in L-arginine-induced experimental acute pancreatitis. Pancreatology
5, 380–386. doi: 10.1159/000086538
Harper, A. A., and Raper, H. S. (1943). Pancreozymin, a stimulant of the secretion
of pancreatic enzymes in extracts of the small intestine. J. Physiol. 102, 115–125.
doi: 10.1113/jphysiol.1943.sp004021
Hartwig, W., Kolvenbach, M., Hackert, T., Fortunato, F., Schneider, L.,
Buchler, M. W., et al. (2007). Enterokinase induces severe necrosis
and rapid mortality in cerulein pancreatitis: characterization of a novel
noninvasive rat model of necro-hemorrhagic pancreatitis. Surgery 142,
327–336. doi: 10.1016/j.surg.2007.04.023
Hartwig, W., Schimmel, E., Hackert, T., Fortunato, F., Bergmann, F., Baczako,
A., et al. (2008). A novel animal model of severe pancreatitis in mice and
its differences to the rat. Surgery 144, 394–403. doi: 10.1016/j.surg.2008.
04.006
He, Z. J., Winston, J. H., Yusuf, T. E., Micci, M. A., Elfert, A., Xiao, S. Y., et al.
(2003). Intraductal administration of an NK1 receptor antagonist attenuates
the inflammatory response to retrograde infusion of radiological contrast
in rats: implications for the pathogenesis and prevention of ERCP-induced
pancreatitis. Pancreas 27, e13–17. doi: 10.1097/00006676-200307000-00018
Hegyi, P., Czako, L., Takacs, T., Szilvassy, Z., and Lonovics, J. (1999).
Pancreatic secretory responses in L-arginine-induced pancreatitis:
comparison of diabetic and nondiabetic rats. Pancreas 19, 167–174.
doi: 10.1097/00006676-199908000-00010
Hegyi, P., Pandol, S., Venglovecz, V., and Rakonczay, Z, Jr. (2011). The acinar-
ductal tango in the pathogenesis of acute pancreatitis. Gut 60, 544–552.
doi: 10.1136/gut.2010.218461
Hegyi, P., and Petersen, O. H. (2013). The exocrine pancreas: the acinar-ductal
tango in physiology and pathophysiology. Rev. Physiol. Biochem. Pharmacol.
165, 1–30. doi: 10.1007/112_2013_14
Frontiers in Physiology | www.frontiersin.org 17 December 2020 | Volume 11 | Article 614591
Yang et al. Experimental Acute Pancreatitis Models
Hegyi, P., Rakonczay, Z, Jr., Sari, R., Gog, C., Lonovics, J., Takacs, T., et al.
(2004). L-arginine-induced experimental pancreatitis. World J. Gastroenterol.
10, 2003–2009. doi: 10.3748/wjg.v10.i14.2003
Hegyi, P., Takacs, T., Jarmay, K., Nagy, I., Czako, L., and Lonovics, J. (1997).
Spontaneous and cholecystokinin-octapeptide-promoted regeneration of the
pancreas following L-arginine-induced pancreatitis in rat. Int. J. Pancreatol.
22, 193–200.
Hegyi, P., Takacs, T., Tiszlavicz, L., Czako, L., and Lonovics, J. (2000).
Recovery of exocrine pancreas six months following pancreatitis induction
with L-arginine in streptozotocin-diabetic rats. J. Physiol. Paris 94, 51–55.
doi: 10.1016/S0928-4257(99)00103-5
Hines, O. J., and Pandol, S. J. (2019). Management of severe acute pancreatitis. BMJ
367:l6227. doi: 10.1136/bmj.l6227
Hoque, R., Sohail, M., Malik, A., Sarwar, S., Luo, Y., Shah, A., et al. (2011). TLR9
and theNLRP3 inflammasome link acinar cell death with inflammation in acute
pancreatitis. Gastroenterology 141, 358–369. doi: 10.1053/j.gastro.2011.03.041
Huang, W., Booth, D. M., Cane, M. C., Chvanov, M., Javed, M. A., Elliott, V. L.,
et al. (2014). Fatty acid ethyl ester synthase inhibition ameliorates ethanol-
induced Ca2+-dependent mitochondrial dysfunction and acute pancreatitis.
Gut 63, 1313–1324. doi: 10.1136/gutjnl-2012-304058
Huang, W., Cane, M. C., Mukherjee, R., Szatmary, P., Zhang, X., Elliott, V.,
et al. (2017). Caffeine protects against experimental acute pancreatitis by
inhibition of inositol 1,4,5-trisphosphate receptor-mediated Ca2+ release. Gut
66, 301–313. doi: 10.1136/gutjnl-2015-309363
Huang, Y. X., Li, W. D., Jia, L., Qiu, J. H., Jiang, S. M., Ou, Y., et al.
(2012). Infliximab enhances the therapeutic effectiveness of octreotide
on acute necrotizing pancreatitis in rat model. Pancreas 41, 849–854.
doi: 10.1097/MPA.0b013e31823fbdc3
Ishii, H., Salem, H. H., Bell, C. E., Laposata, E. A., and Majerus, P. W. (1986).
Thrombomodulin, an endothelial anticoagulant protein, is absent from the
human brain. Blood 67, 362–365. doi: 10.1182/blood.V67.2.362.362
Ivy, A. C. (1929). A hormone mechanism for gall-bladder contraction &
evacuation. Am. J. Surg. 7, 455–459. doi: 10.1016/S0002-9610(29)90551-1
Jakubowska, M. A., Ferdek, P. E., Gerasimenko, O. V., Gerasimenko, J. V., and
Petersen, O. H. (2016). Nitric oxide signals are interlinked with calcium signals
in normal pancreatic stellate cells upon oxidative stress and inflammation.Open
Biol. 6:160149. doi: 10.1098/rsob.160149
Jancar, S., De Giaccobi, G., Mariano, M., Mencia-Huerta, J. M., Sirois, P., and
Braquet, P. (1988). Immune complex induced pancreatitis: effect of BN 52021,
a selective antagonist of platelet-activating factor. Prostaglandins 35, 757–770.
doi: 10.1016/0090-6980(88)90148-7
Jancso, Z., Hegyi, E., and Sahin-Toth, M. (2018). Chymotrypsin reduces the
severity of secretagogue-induced pancreatitis in mice. Gastroenterology 155,
1017–1021. doi: 10.1053/j.gastro.2018.06.041
Jancso, Z., and Sahin-Toth, M. (2020). Mutation that promotes activation of
trypsinogen increases severity of secretagogue-induced pancreatitis in mice.
Gastroenterology 158, 1083–1094. doi: 10.1053/j.gastro.2019.11.020
Janigan, D. T., Nevalainen, T. J., MacAulay, M. A., and Vethamany, V. G.
(1975). Foreign serum-induced pancreatitis in mice. I. A new model of acute
pancreatitis. Lab. Invest. 33, 591–607.
Ji, B., Bi, Y., Simeone, D., Mortensen, R. M., and Logsdon, C. D. (2001).
Human pancreatic acinar cells lack functional responses to cholecystokinin
and gastrin. Gastroenterology 121, 1380–1390. doi: 10.1053/gast.2001.
29557
Jin, H. T., Lamsa, T., Hyvonen, M. T., Sand, J., Raty, S., Grigorenko, N., et al.
(2008). A polyamine analog bismethylspermine ameliorates severe pancreatitis
induced by intraductal infusion of taurodeoxycholate. Surgery 144, 49–56.
doi: 10.1016/j.surg.2008.03.029
Jin, H. T., Lamsa, T., Nordback, P. H., Hyvonen, M. T., Raty, S., Nordback,
I., et al. (2011). Polyamine catabolism in relation to trypsin activation
and apoptosis in experimental acute pancreatitis. Pancreatology 11, 83–91.
doi: 10.1159/000327260
Jin, S., Orabi, A. I., Le, T., Javed, T. A., Sah, S., Eisses, J. F., et al. (2015). Exposure
to radiocontrast agents induces pancreatic inflammation by activation of
nuclear factor-kappaB, calcium signaling, and calcineurin. Gastroenterology
149, 753–764.e711. doi: 10.1053/j.gastro.2015.05.004
Johnson, C. D., Kingsnorth, A. N., Imrie, C. W., McMahon, M. J., Neoptolemos,
J. P., McKay, C., et al. (2001). Double blind, randomised, placebo controlled
study of a platelet activating factor antagonist, lexipafant, in the treatment
and prevention of organ failure in predicted severe acute pancreatitis. Gut 48,
62–69. doi: 10.1136/gut.48.1.62
Jung, K. H., Song, S. U., Yi, T., Jeon, M. S., Hong, S. W., Zheng, H. M., et al.
(2011). Human bone marrow-derived clonal mesenchymal stem cells inhibit
inflammation and reduce acute pancreatitis in rats. Gastroenterology 140,
998–1008. doi: 10.1053/j.gastro.2010.11.047
Kanno, H., Nose, M., Itoh, J., Taniguchi, Y., and Kyogoku, M. (1992).
Spontaneous development of pancreatitis in the MRL/Mp strain of
mice in autoimmune mechanism. Clin. Exp. Immunol. 89, 68–73.
doi: 10.1111/j.1365-2249.1992.tb06879.x
Katz, M., Carangelo, R., Miller, L. J., and Gorelick, F. (1996). Effect of ethanol on
cholecystokinin-stimulated zymogen conversion in pancreatic acinar cells. Am.
J. Physiol. 270, G171–175. doi: 10.1152/ajpgi.1996.270.1.G171
Kim, J., Koo, B. K., and Knoblich, J. A. (2020). Human organoids: model systems
for human biology and medicine. Nat. Rev. Mol. Cell Biol. 21, 571–584.
doi: 10.1038/s41580-020-0259-3
Kingsnorth, A. N. (1996). Platelet-activating factor. Scand. J. Gastroenterol. Suppl.
219, 28–31. doi: 10.3109/00365529609104996
Kingsnorth, A. N., Galloway, S. W., and Formela, L. J. (1995). Randomized,
double-blind phase II trial of lexipafant, a platelet-activating factor
antagonist, in human acute pancreatitis. Br. J. Surg. 82, 1414–1420.
doi: 10.1002/bjs.1800821039
Kishino, Y., and Kawamura, S. (1984). Pancreatic damage induced by injecting
a large dose of arginine. Virchows Arch. B. Cell Pathol. 47, 147–155.
doi: 10.1007/BF02890197
Kivisaari, L. (1979). Contrast absorption and pancreatic inflammation
following experimental ERCP. Invest. Radiol. 14, 493–497.
doi: 10.1097/00004424-197911000-00008
Klop, B., do Rego, A. T., and Cabezas, M. C. (2013). Alcohol
and plasma triglycerides. Curr. Opin. Lipidol. 24, 321–326.
doi: 10.1097/MOL.0b013e3283606845
Kubisch, C. H., Sans, M. D., Arumugam, T., Ernst, S. A., Williams, J. A.,
and Logsdon, C. D. (2006). Early activation of endoplasmic reticulum
stress is associated with arginine-induced acute pancreatitis. Am. J. Physiol.
Gastrointest. Liver Physiol. 291, G238–245. doi: 10.1152/ajpgi.00471.2005
Kui, B., Balla, Z., Vasas, B., Vegh, E. T., Pallagi, P., Kormanyos, E. S., et al. (2015).
New insights into the methodology of L-arginine-induced acute pancreatitis.
PLoS ONE 10:e0117588. doi: 10.1371/journal.pone.0117588
Kuntz, E., Pinget, M., and Damge, P. (2004). Cholecystokinin octapeptide: a
potential growth factor for pancreatic beta cells in diabetic rats. JOP 5, 464–475.
Lampel,M., and Kern, H. F. (1977). Acute interstitial pancreatitis in the rat induced
by excessive doses of a pancreatic secretagogue. Virchows Arch. A Pathol. Anat.
Histol. 373, 97–117. doi: 10.1007/BF00432156
Laposata, E. A., and Lange, L. G. (1986). Presence of nonoxidative ethanol
metabolism in human organs commonly damaged by ethanol abuse. Science
231, 497–499. doi: 10.1126/science.3941913
Laukkarinen, J. M., Van Acker, G. J., Weiss, E. R., Steer, M. L., and
Perides, G. (2007). A mouse model of acute biliary pancreatitis induced by
retrograde pancreatic duct infusion of Na-taurocholate. Gut 56, 1590–1598.
doi: 10.1136/gut.2007.124230
Le, T., Eisses, J. F., Lemon, K. L., Ozolek, J. A., Pociask, D. A., Orabi, A. I., et al.
(2015). Intraductal infusion of taurocholate followed by distal common bile
duct ligation leads to a severe necrotic model of pancreatitis in mice. Pancreas
44, 493–499. doi: 10.1097/MPA.0000000000000285
Leblond, C. P., and Sergeyeva, M. A. (1944). Vacuolation of the acinar cells in the
pancreas of the rat after treatment with thyroxine or acetylcholine. Anat. Rec.
90, 235–242. doi: 10.1002/ar.1090900308
Lee, M. G., Ohana, E., Park, H. W., Yang, D., and Muallem, S. (2012). Molecular
mechanism of pancreatic and salivary gland fluid and HCO3 secretion. Physiol.
Rev. 92, 39–74. doi: 10.1152/physrev.00011.2011
Lerch, M. M., and Aghdassi, A. A. (2010). The role of bile acids
in gallstone-induced pancreatitis. Gastroenterology 138, 429–433.
doi: 10.1053/j.gastro.2009.12.012
Lerch, M. M., and Gorelick, F. S. (2013). Models of acute and chronic pancreatitis.
Gastroenterology 144, 1180–1193. doi: 10.1053/j.gastro.2012.12.043
Lerch, M. M., Saluja, A. K., Dawra, R., Ramarao, P., Saluja, M., and Steer,
M. L. (1992). Acute necrotizing pancreatitis in the opossum: earliest
Frontiers in Physiology | www.frontiersin.org 18 December 2020 | Volume 11 | Article 614591
Yang et al. Experimental Acute Pancreatitis Models
morphological changes involve acinar cells. Gastroenterology 103, 205–213.
doi: 10.1016/0016-5085(92)91114-J
Lerch,M.M., Saluja, A. K., Runzi, M., Dawra, R., Saluja, M., and Steer,M. L. (1993).
Pancreatic duct obstruction triggers acute necrotizing pancreatitis in the
opossum. Gastroenterology 104, 853–861. doi: 10.1016/0016-5085(93)91022-A
Lerch, M. M., Saluja, A. K., Runzi, M., Dawra, R., and Steer, M. L. (1995a).
Luminal endocytosis and intracellular targeting by acinar cells during
early biliary pancreatitis in the opossum. J. Clin. Invest. 95, 2222–2231.
doi: 10.1172/JCI117912
Lerch, M. M., Weidenbach, H., Gress, T. M., and Adler, G. (1995b). Effect of kinin
inhibition in experimental acute pancreatitis. Am. J. Physiol. 269, G490–499.
doi: 10.1152/ajpgi.1995.269.4.G490
Lerch, M. M., Zenker, M., Turi, S., and Mayerle, J. (2006). Developmental and
metabolic disorders of the pancreas. Endocrinol. Metab. Clin. North Am. 35,
219–241. doi: 10.1016/j.ecl.2006.02.004
Letko, G., Mantke, R., Sokolowski, A., and Spormann, H. (1990). Enzymatic and
histologic investigations into the course of pancreatic alterations induced by
anti-acinar-cell-antiserum. Int. Surg. 75, 254–258.
Leveau, P., Wang, X., Sun, Z., Borjesson, A., Andersson, E., and Andersson, R.
(2005). Severity of pancreatitis-associated gut barrier dysfunction is reduced
following treatment with the PAF inhibitor lexipafant. Biochem. Pharmacol. 69,
1325–1331. doi: 10.1016/j.bcp.2005.01.023
Lombardi, B., and Rao, N. K. (1975). Acute hemorrhagic pancreatic necrosis in
mice. Influence of the age and sex of the animals and of dietary ethionine,
choline, methionine, and adenine sulfate. Am. J. Pathol. 81, 87–100.
Lopez-Font, I., Gea-Sorli, S., de-Madaria, E., Gutierrez, L. M., Perez-Mateo,
M., and Closa, D. (2010). Pancreatic and pulmonary mast cells activation
during experimental acute pancreatitis. World J. Gastroenterol. 16, 3411–3417.
doi: 10.3748/wjg.v16.i27.3411
Louhimo, J., Steer, M. L., and Perides, G. (2016). Necroptosis is an important
severity determinant and potential therapeutic target in experimental
severe pancreatitis. Cell Mol. Gastroenterol. Hepatol. 2, 519–535.
doi: 10.1016/j.jcmgh.2016.04.002
Lu, Z., Karne, S., Kolodecik, T., and Gorelick, F. S. (2002). Alcohols enhance
caerulein-induced zymogen activation in pancreatic acinar cells. Am. J. Physiol.
Gastrointest. Liver Physiol. 282, G501–507. doi: 10.1152/ajpgi.00388.2001
Lugea, A., Gerloff, A., Su, H. Y., Xu, Z., Go, A., Hu, C., et al. (2017a). The
combination of alcohol and cigarette smoke induces endoplasmic reticulum
stress and cell death in pancreatic acinar cells.Gastroenterology 153, 1674–1686.
doi: 10.1053/j.gastro.2017.08.036
Lugea, A., Gong, J., Nguyen, J., Nieto, J., French, S. W., and Pandol, S. J. (2010).
Cholinergic mediation of alcohol-induced experimental pancreatitis. Alcohol.
Clin. Exp. Res. 34, 1768–1781. doi: 10.1111/j.1530-0277.2010.01264.x
Lugea, A., Waldron, R. T., Mareninova, O. A., Shalbueva, N., Deng, N., Su, H.
Y., et al. (2017b). Human pancreatic acinar cells: proteomic characterization,
physiologic responses, and organellar disorders in ex vivo pancreatitis. Am. J.
Pathol. 187, 2726–2743. doi: 10.1016/j.ajpath.2017.08.017
Luo, S., Wang, R., Jiang, W., Lin, X., Qiu, P., and Yan, G. (2010). A novel
recombinant snake venommetalloproteinase from Agkistrodon acutus protects
against taurocholate-induced severe acute pancreatitis in rats. Biochimie 92,
1354–1361. doi: 10.1016/j.biochi.2010.06.018
Madhi, R., Rahman, M., Taha, D., Morgelin, M., and Thorlacius, H. (2019).
Targeting peptidylarginine deiminase reduces neutrophil extracellular trap
formation and tissue injury in severe acute pancreatitis. J. Cell. Physiol. 234,
11850–11860. doi: 10.1002/jcp.27874
Maleth, J., Balazs, A., Pallagi, P., Balla, Z., Kui, B., Katona, M., et al. (2015). Alcohol
disrupts levels and function of the cystic fibrosis transmembrane conductance
regulator to promote development of pancreatitis. Gastroenterology 148,
427–439.e416. doi: 10.1053/j.gastro.2014.11.002
Mareninova, O. A., Hermann, K., French, S. W., O’Konski, M. S., Pandol, S. J.,
Webster, P., et al. (2009). Impaired autophagic flux mediates acinar cell vacuole
formation and trypsinogen activation in rodent models of acute pancreatitis. J.
Clin. Invest. 119, 3340–3355. doi: 10.1172/JCI38674
Mayerle, J., Sendler, M., Hegyi, E., Beyer, G., Lerch, M. M., and Sahin-Toth,
M. (2019). Genetics, cell biology, and pathophysiology of pancreatitis.
Gastroenterology 156, 1951–1968.e1951. doi: 10.1053/j.gastro.2018.
11.081
McCune, W. S., Shorb, P. E., and Moscovitz, H. (1968). Endoscopic cannulation
of the ampulla of vater: a preliminary report. Ann. Surg. 167, 752–756.
doi: 10.1097/00000658-196805000-00013
Meczker, A., Hanak, L., Parniczky, A., Szentesi, A., Eross, B., Hegyi, P., et al. (2020).
Analysis of 1060 cases of drug-induced acute pancreatitis.Gastroenterology 159,
1958–1961.e8. doi: 10.1053/j.gastro.2020.07.016
Merkord, J., and Hennighausen, G. (1989). Acute pancreatitis and bile duct
lesions in rat induced by dibutyltin dichloride. Exp. Pathol. 36, 59–62.
doi: 10.1016/S0232-1513(89)80113-6
Merriam, L. T.,Wilcockson, D., Samuel, I., and Joehl, R. J. (1996). Ligation-induced
acute pancreatitis increases pancreatic circulating trypsinogen activation
peptides. J. Surg. Res. 60, 417–421. doi: 10.1006/jsre.1996.0068
Meyerholz, D. K., and Samuel, I. (2007). Morphologic characterization of
early ligation-induced acute pancreatitis in rats. Am. J. Surg. 194, 652–658.
doi: 10.1016/j.amjsurg.2007.07.014
Meyerholz, D. K., Williard, D. E., Grittmann, A. M., and Samuel, I. (2008). Murine
pancreatic duct ligation induces stress kinase activation, acute pancreatitis, and
acute lung injury.Am. J. Surg. 196, 675–682. doi: 10.1016/j.amjsurg.2008.07.009
Michael, E. S., Kuliopulos, A., Covic, L., Steer, M. L., and Perides, G. (2013).
Pharmacological inhibition of PAR2with the pepducin P2pal-18S protects mice
against acute experimental biliary pancreatitis. Am. J. Physiol. Gastrointest.
Liver Physiol. 304, G516–526. doi: 10.1152/ajpgi.00296.2012
Mizunuma, T., Kawamura, S., and Kishino, Y. (1984). Effects of injecting excess
arginine on rat pancreas. J. Nutr. 114, 467–471. doi: 10.1093/jn/114.3.467
Moggia, E., Koti, R., Belgaumkar, A. P., Fazio, F., Pereira, S. P., Davidson, B. R.,
et al. (2017). Pharmacological interventions for acute pancreatitis. Cochrane
Database Syst. Rev. 4:CD011384. doi: 10.1002/14651858.CD011384.pub2
Mole, D. J., Webster, S. P., Uings, I., Zheng, X., Binnie, M., Wilson, K.,
et al. (2016). Kynurenine-3-monooxygenase inhibition prevents multiple organ
failure in rodent models of acute pancreatitis. Nat. Med. 22, 202–209.
doi: 10.1038/nm.4020
Molnar, R., Madacsy, T., Varga, A., Nemeth, M., Katona, X., Gorog, M.,
et al. (2020). Mouse pancreatic ductal organoid culture as a relevant
model to study exocrine pancreatic ion secretion. Lab. Invest. 100, 84–97.
doi: 10.1038/s41374-019-0300-3
Mooren, F., Hlouschek, V., Finkes, T., Turi, S., Weber, I. A., Singh, J., et al. (2003).
Early changes in pancreatic acinar cell calcium signaling after pancreatic duct
obstruction. J. Biol. Chem. 278, 9361–9369. doi: 10.1074/jbc.M207454200
Mouret, J. (1895). Contribution à l’étude des cellules glandulaires (pancreas). J.
Anat. Physiol. 31, 221–236.
Mukherjee, R., Mareninova, O. A., Odinokova, I. V., Huang, W., Murphy,
J., Chvanov, M., et al. (2016). Mechanism of mitochondrial permeability
transition pore induction and damage in the pancreas: inhibition prevents
acute pancreatitis by protecting production of ATP. Gut 65, 1333–1346.
doi: 10.1136/gutjnl-2014-308553
Mukherjee, R., Nunes, Q., Huang, W., and Sutton, R. (2019). Precision medicine
for acute pancreatitis: current status and future opportunities. Precis. Clin. Med.
2, 81–86. doi: 10.1093/pcmedi/pbz010
Murphy, J. A., Criddle, D. N., Sherwood, M., Chvanov, M., Mukherjee, R.,
McLaughlin, E., et al. (2008). Direct activation of cytosolic Ca2+ signaling
and enzyme secretion by cholecystokinin in human pancreatic acinar cells.
Gastroenterology 135, 632–641. doi: 10.1053/j.gastro.2008.05.026
Murthy, P., Singhi, A. D., Ross, M. A., Loughran, P., Paragomi, P., Papachristou,
G. I., et al. (2019). Enhanced neutrophil extracellular trap formation in acute
pancreatitis contributes to disease severity and is reduced by chloroquine.
Front. Immunol. 10:28. doi: 10.3389/fimmu.2019.00028
Navina, S., Acharya, C., DeLany, J. P., Orlichenko, L. S., Baty, C. J., Shiva,
S. S., et al. (2011). Lipotoxicity causes multisystem organ failure and
exacerbates acute pancreatitis in obesity. Sci. Transl. Med. 3:107ra110.
doi: 10.1126/scitranslmed.3002573
Nevalainen, T. J. (1978). Pancreatic injury caused by intraductal injection of
foreign serum in rat. Virchows Arch. B Cell Pathol. 27, 89–98.
Nevalainen, T. J., Fowlie, F. E., and Janigan, D. T. (1977). Foreign serum-induced
pancreatitis in mice. II. Secretory disturbances of acinar cells. Lab. Invest.
36, 469–473.
Niederau, C., Ferrell, L. D., and Grendell, J. H. (1985). Caerulein-
induced acute necrotizing pancreatitis in mice: protective effects of
Frontiers in Physiology | www.frontiersin.org 19 December 2020 | Volume 11 | Article 614591
Yang et al. Experimental Acute Pancreatitis Models
proglumide, benzotript, and secretin. Gastroenterology 88, 1192–1204.
doi: 10.1016/S0016-5085(85)80079-2
Nieuwenhuijs, V. B., van Dijk, J. E., Gooszen, H. G., and Akkermans, L.
M. (2000). Obstructive jaundice, bacterial translocation and interdigestive
small-bowel motility in rats. Digestion 62, 255–261. doi: 10.1159/0000
07824
Noble, M. D., Romac, J., Vigna, S. R., and Liddle, R. A. (2008). A pH-sensitive,
neurogenic pathway mediates disease severity in a model of post-ERCP
pancreatitis. Gut 57, 1566–1571. doi: 10.1136/gut.2008.148551
Noel, P., Patel, K., Durgampudi, C., Trivedi, R. N., de Oliveira, C., Crowell, M. D.,
et al. (2016). Peripancreatic fat necrosis worsens acute pancreatitis independent
of pancreatic necrosis via unsaturated fatty acids increased in human pancreatic
necrosis collections. Gut 65, 100–111. doi: 10.1136/gutjnl-2014-308043
Novaes, G., Cabral, A. P., de Falco, C. N., and de Queiroz, A. C. (1989). Acute
pancreatitis induced by scorpion toxin, tityustoxin. Histopathological study in
rats. Arq. Gastroenterol. 26, 9–12.
Odinokova, I. V., Sung, K. F., Mareninova, O. A., Hermann, K., Evtodienko, Y.,
Andreyev, A., et al. (2009). Mechanisms regulating cytochrome c release in
pancreatic mitochondria. Gut 58, 431–442. doi: 10.1136/gut.2007.147207
Opie, E. L. (1901). The etiology of acute hemorrhagic pancreatitis. Bull. Johns
Hopkins Hosp. 12, 182–190.
Pan, Y., Fang, H. Z., Lu, F. C., Pan, M. G., Chen, F., Xiong, P.,
et al. (2017). Ulinastatin ameliorates tissue damage of severe acute
pancreatitis through modulating regulatory T cells. J. Inflamm. Lond. 14:7.
doi: 10.1186/s12950-017-0154-7
Pandol, S. J., Gukovsky, I., Satoh, A., Lugea, A., and Gukovskaya, A. S. (2003).
Animal and in vitro models of alcoholic pancreatitis: role of cholecystokinin.
Pancreas 27, 297–300. doi: 10.1097/00006676-200311000-00004
Pandol, S. J., Periskic, S., Gukovsky, I., Zaninovic, V., Jung, Y., Zong, Y.,
et al. (1999). Ethanol diet increases the sensitivity of rats to pancreatitis
induced by cholecystokinin octapeptide. Gastroenterology 117, 706–716.
doi: 10.1016/S0016-5085(99)70465-8
Pantoja, J. L., Renner, I. G., Abramson, S. B., and Edmondson, H. A.
(1983). Production of acute hemorrhagic-pancreatitis in the dog using
venom of the scorpion, buthus-quinquestriatus. Dig. Dis. Sci. 28, 429–439.
doi: 10.1007/BF02430532
Parekh, P. J., Majithia, R., Sikka, S. K., and Baron, T. H. (2017). The
“scope” of post-ERCP pancreatitis. Mayo Clin. Proc. 92, 434–448.
doi: 10.1016/j.mayocp.2016.10.028
Paszt, A., Takacs, T., Rakonczay, Z., Kaszaki, J., Wolfard, A., Tiszlavicz, L., et al.
(2004). The role of the glucocorticoid-dependentmechanism in the progression
of sodium taurocholate-induced acute pancreatitis in the rat. Pancreas 29,
75–82. doi: 10.1097/00006676-200407000-00059
Patel, K., Trivedi, R. N., Durgampudi, C., Noel, P., Cline, R. A., DeLany, J. P., et al.
(2015). Lipolysis of visceral adipocyte triglyceride by pancreatic lipases converts
mild acute pancreatitis to severe pancreatitis independent of necrosis and
inflammation. Am. J. Pathol. 185, 808–819. doi: 10.1016/j.ajpath.2014.11.019
Perides, G., Laukkarinen, J. M., Vassileva, G., and Steer, M. L. (2010).
Biliary acute pancreatitis in mice is mediated by the G-protein-coupled
cell surface bile acid receptor Gpbar1. Gastroenterology 138, 715–725.
doi: 10.1053/j.gastro.2009.10.052
Perides, G., Tao, X., West, N., Sharma, A., and Steer, M. L. (2005). A
mouse model of ethanol dependent pancreatic fibrosis. Gut 54, 1461–1467.
doi: 10.1136/gut.2004.062919
Petho, G., and Reeh, P. W. (2012). Sensory and signaling mechanisms of
bradykinin, eicosanoids, platelet-activating factor, and nitric oxide in peripheral
nociceptors. Physiol. Rev. 92, 1699–1775. doi: 10.1152/physrev.00048.2010
Petrov, M. S., and Yadav, D. (2019). Global epidemiology and holistic
prevention of pancreatitis. Nat. Rev. Gastroenterol. Hepatol. 16, 175–184.
doi: 10.1038/s41575-018-0087-5
Pozsar, J., Schwab, R., Simon, K., Fekete, L., Orgovan, G., and Pap, A. (1997).
Effect of endotoxin administration on the severity of acute pancreatitis in two
experimental models. Int. J. Pancreatol. 22, 31–37. doi: 10.1007/BF02803902
Qian, M., Fang, L., and Cui, Y. (2010). Expression of NOD2 in a rat model of acute
pancreatitis. Pancreas 39, 1034–1040. doi: 10.1097/MPA.0b013e3181da0f1d
Radadiya, D., Devani, K., Arora, S., Charilaou, P., Brahmbhatt, B., Young,
M., et al. (2019). Peri-procedural aggressive hydration for post endoscopic
retrograde cholangiopancreatography (ERCP) pancreatitis prophylaxsis:
meta-analysis of randomized controlled trials. Pancreatology 19, 819–827.
doi: 10.1016/j.pan.2019.07.046
Rakonczay, Z, Jr., Hegyi, P., Dosa, S., Ivanyi, B., Jarmay, K., Biczo, G., et al. (2008).
A new severe acute necrotizing pancreatitis model induced by L-ornithine in
rats. Crit. Care Med. 36, 2117–2127. doi: 10.1097/CCM.0b013e31817d7f5c
Rakonczay, Z, Jr., Jarmay, K., Kaszaki, J., Mandi, Y., Duda, E., Hegyi,
P., et al. (2003). NF-kappaB activation is detrimental in arginine-
induced acute pancreatitis. Free Radic. Biol. Med. 34, 696–709.
doi: 10.1016/S0891-5849(02)01373-4
Rattner, D. W., Napolitano, L. M., Corsetti, J., Compton, C., Stanford, G. G.,
Warshaw, A. L., et al. (1990). Hypocalcemia in experimental pancreatitis
occurs independently of changes in serum nonesterified fatty acid levels. Int.
J. Pancreatol. 6, 249–262.
Reeve, J. R, Jr., Wu, S. V., Keire, D. A., Faull, K., Chew, P., Solomon,
T. E., et al. (2004). Differential bile-pancreatic secretory effects of CCK-
58 and CCK-8. Am. J. Physiol. Gastrointest. Liver Physiol. 286, G395–402.
doi: 10.1152/ajpgi.00020.2003
Rifai, Y., Elder, A. S., Carati, C. J., Hussey, D. J., Li, X., Woods, C. M., et al.
(2008). The tripeptide analog feG ameliorates severity of acute pancreatitis
in a caerulein mouse model. Am. J. Physiol. Gastrointest. Liver Physiol. 294,
G1094–1099. doi: 10.1152/ajpgi.00534.2007
Rosen, H. R., and Tuchler, H. (1992). Pulmonary injury in acute experimental
pancreatitis correlates with elevated levels of free fatty acids in rats. HPB Surg.
6, 79–90. doi: 10.1155/1992/92916
Saka, M., Tuzun, A., Ates, Y., Bagci, S., Karaeren, N., and Dagalp, K. (2004). Acute
pancreatitis possibly due to arginine use: a case report. Turk. J. Gastroenterol.
15, 56–58.
Saluja, A., Dudeja, V., Dawra, R., and Sah, R. P. (2019). Early Intra-acinar
events in pathogenesis of pancreatitis. Gastroenterology 156, 1979–1993.
doi: 10.1053/j.gastro.2019.01.268
Saluja, A. K., Bhagat, L., Lee, H. S., Bhatia, M., Frossard, J. L., and
Steer, M. L. (1999). Secretagogue-induced digestive enzyme activation
and cell injury in rat pancreatic acini. Am. J. Physiol. 276, G835–842.
doi: 10.1152/ajpgi.1999.276.4.G835
Saluja, A. K., Lerch, M. M., Phillips, P. A., and Dudeja, V. (2007). Why does
pancreatic overstimulation cause pancreatitis? Annu. Rev. Physiol. 69, 249–269.
doi: 10.1146/annurev.physiol.69.031905.161253
Samuel, I., Yuan, Z., Meyerholz, D. K., Twait, E., Williard, D. E., and Kempuraj,
D. (2010). A novel model of severe gallstone pancreatitis: murine pancreatic
duct ligation results in systemic inflammation and substantial mortality.
Pancreatology 10, 536–544. doi: 10.1159/000320776
Saruc, M., Yuceyar, H., Turkel, N., Ozutemiz, O., Tuzcuoglu, I., Yuce, G., et al.
(2003). An experimental model of hemolysis-induced acute pancreatitis. Braz.
J. Med. Biol. Res. 36, 879–886. doi: 10.1590/S0100-879X2003000700008
Schmidt, J., Lewandrowsi, K., Warshaw, A. L., Compton, C. C., and Rattner, D.
W. (1992a). Morphometric characteristics and homogeneity of a new model of
acute pancreatitis in the rat. Int. J. Pancreatol. 12, 41–51.
Schmidt, J., Rattner, D. W., Lewandrowski, K., Compton, C. C., Mandavilli, U.,
Knoefel,W. T., et al. (1992b). A better model of acute pancreatitis for evaluating
therapy. Ann. Surg. 215, 44–56. doi: 10.1097/00000658-199201000-00007
Seelig, R., and Seelig, H. P. (1975). The possible role of serum complement
system in the formal pathogenesis of acute pancreatitis II. Cobra venom
factor pancreatitis–sodiumtaurocholate and deoxycholate pancreatitis. Acta
Hepatogastroenterol. 22, 335–346.
Sendler, M., Weiss, F. U., Golchert, J., Homuth, G., van den Brandt,
C., Mahajan, U. M., et al. (2018). Cathepsin B-mediated activation of
trypsinogen in endocytosing macrophages increases severity of pancreatitis
in mice. Gastroenterology 154, 704–718.e710. doi: 10.1053/j.gastro.2017.
10.018
Shalbueva, N., Mareninova, O. A., Gerloff, A., Yuan, J., Waldron, R. T.,
Pandol, S. J., et al. (2013). Effects of oxidative alcohol metabolism
on the mitochondrial permeability transition pore and necrosis in a
mouse model of alcoholic pancreatitis. Gastroenterology 144, 437–446.e436.
doi: 10.1053/j.gastro.2012.10.037
Shields, C. J., Sookhai, S., Winter, D. C., Dowdall, J. F., Kingston, G.,
Parfrey, N., et al. (2001). Attenuation of pancreatitis-induced pulmonary
injury by aerosolized hypertonic saline. Surg. Infect. 2, 215–223.
doi: 10.1089/109629601317202696
Frontiers in Physiology | www.frontiersin.org 20 December 2020 | Volume 11 | Article 614591
Yang et al. Experimental Acute Pancreatitis Models
Shorrock, K., Austen, B. M., and Hermon-Taylor, J. (1991). Hyperstimulation
pancreatitis in mice induced by cholecystokinin octapeptide, caerulein, and
novel analogues: effect of molecular structure on potency. Pancreas 6, 404–406.
doi: 10.1097/00006676-199107000-00005
Silva-Vaz, P., Abrantes, A. M., Castelo-Branco, M., Gouveia, A., Botelho, M. F., and
Tralhao, J. G. (2019). Murine models of acute pancreatitis: a critical appraisal
of clinical relevance. Int. J. Mol. Sci. 20:2794. doi: 10.3390/ijms20112794
Siriwardena, A. K., Mason, J. M., Balachandra, S., Bagul, A., Galloway, S.,
Formela, L., et al. (2007). Randomised, double blind, placebo controlled trial
of intravenous antioxidant (n-acetylcysteine, selenium, vitamin C) therapy in
severe acute pancreatitis. Gut 56, 1439–1444. doi: 10.1136/gut.2006.115873
Siveke, J. T., Lubeseder-Martellato, C., Lee, M., Mazur, P. K., Nakhai, H., Radtke, F.,
et al. (2008). Notch signaling is required for exocrine regeneration after acute
pancreatitis. Gastroenterology 134, 544–555. doi: 10.1053/j.gastro.2007.11.003
Sugita, H., Yamaguchi, Y., Ikei, S., Yamada, S., and Ogawa, M. (1997).
Enhanced expression of cytokine-induced neutrophil chemoattractant (CINC)
by bronchoalveolar macrophages in cerulein-induced pancreatitis rats.Dig. Dis.
Sci. 42, 154–160. doi: 10.1023/A:1018809810561
Sun, W., Watanabe, Y., Toki, A., and Wang, Z. Q. (2007). Beneficial effects
of hydrocortisone in induced acute pancreatitis of rats. Chin. Med. J. 120,
1757–1761. doi: 10.1097/00029330-200710020-00005
Sun, W., Watanabe, Y., and Wang, Z. Q. (2006). Expression and significance
of ICAM-1 and its counter receptors LFA-1 and Mac-1 in experimental
acute pancreatitis of rats. World J. Gastroenterol. 12, 5005–5009.
doi: 10.3748/wjg.v12.i31.5005
Szabolcs, A., Reiter, R. J., Letoha, T., Hegyi, P., Papai, G., Varga, I.,
et al. (2006). Effect of melatonin on the severity of L-arginine-induced
experimental acute pancreatitis in rats. World J. Gastroenterol. 12, 251–258.
doi: 10.3748/wjg.v12.i2.251
Sztefko, K., and Panek, J. (2001). Serum free fatty acid concentration in patients
with acute pancreatitis. Pancreatology 1, 230–236. doi: 10.1159/000055816
Takacs, T., Czako, L., Jarmay, K., Farkas, G, Jr., Mandi, Y., and Lonovics, J. (1996).
Cytokine level changes in L-arginine-induced acute pancreatitis in rat. Acta
Physiol. Hung. 84, 147–156.
Takacs, T., Czako, L., Morschl, E., Laszlo, F., Tiszlavicz, L., Rakonczay,
Z, Jr., et al. (2002a). The role of nitric oxide in edema formation
in L-arginine-induced acute pancreatitis. Pancreas 25, 277–282.
doi: 10.1097/00006676-200210000-00010
Takacs, T., Hegyi, P., Jarmay, K., Czako, L., Gog, C., Rakonczay, Z, Jr., et al.
(2001). Cholecystokinin fails to promote pancreatic regeneration in diabetic
rats following the induction of experimental pancreatitis. Pharmacol. Res. 44,
363–372. doi: 10.1006/phrs.2001.0843
Takacs, T., Rakonczay, Z, Jr., Varga, I. S., Ivanyi, B., Mandi, Y., Boros, I.,
et al. (2002b). Comparative effects of water immersion pretreatment on three
different acute pancreatitis models in rats. Biochem. Cell Biol. 80, 241–251.
doi: 10.1139/o02-006
Tardini, A., Anversa, P., Bordi, C., Bertaccini, G., and Impicciatore, M. (1971).
Ultrastructural and biochemical changes after marked caerulein stimulation of
the exocrine pancreas in the dog. Am. J. Pathol. 62, 35–56.
Tashiro, M., Schafer, C., Yao, H., Ernst, S. A., and Williams, J. A. (2001). Arginine
induced acute pancreatitis alters the actin cytoskeleton and increases heat
shock protein expression in rat pancreatic acinar cells. Gut 49, 241–250.
doi: 10.1136/gut.49.2.241
Tekin, S. O., Teksoz, S., Terzioglu, D., Arikan, A. E., Ozcevik, H., and Uslu, E.
(2015). Use of infliximab in treatment of acute pancreatitis. Bratisl. Lek. Listy.
116, 167–172. doi: 10.4149/BLL_2015_034
Terry, T. R., Grant, D. A., and Hermon-Taylor, J. (1987). Intraduct enterokinase
is lethal in rats with experimental bile-salt pancreatitis. Br. J. Surg. 74, 40–43.
doi: 10.1002/bjs.1800740113
Thorn, P., Lawrie, A. M., Smith, P. M., Gallacher, D. V., and Petersen,
O. H. (1993). Local and global cytosolic Ca2+ oscillations in exocrine
cells evoked by agonists and inositol trisphosphate. Cell 74, 661–668.
doi: 10.1016/0092-8674(93)90513-P
Toma, H., Winston, J., Micci, M. A., Shenoy, M., and Pasricha, P. J.
(2000). Nerve growth factor expression is up-regulated in the rat model
of L-arginine-induced acute pancreatitis. Gastroenterology 119, 1373–1381.
doi: 10.1053/gast.2000.19264
Venglovecz, V., Rakonczay, Z, Jr., Ozsvari, B., Takacs, T., Lonovics, J.,
Varro, A., et al. (2008). Effects of bile acids on pancreatic ductal
bicarbonate secretion in guinea pig. Gut 57, 1102–1112. doi: 10.1136/gut.2007.
134361
Vigna, S. R., Shahid, R. A., and Liddle, R. A. (2014). Ethanol contributes
to neurogenic pancreatitis by activation of TRPV1. FASEB J. 28, 891–896.
doi: 10.1096/fj.13-236208
Villaret, M., Justin-Besancon, L., and Even, R. (1929). Effects de l’acetylcholine sur
la secretion pancreatique. C R Soc Biol. 101:70.
Waldron, R. T., Chen, Y., Pham, H., Go, A., Su, H. Y., Hu, C., et al. (2019). The
Orai Ca2+ channel inhibitor CM4620 targets both parenchymal and immune
cells to reduce inflammation in experimental acute pancreatitis. J. Physiol. 597,
3085–3105. doi: 10.1113/JP277856
Walker, N. I., Winterford, C. M., and Kerr, J. F. (1992). Ultrastructure of
the rat pancreas after experimental duct ligation. II. Duct and stromal
cell proliferation, differentiation, and deletion. Pancreas 7, 420–434.
doi: 10.1097/00006676-199207000-00002
Wan, M. H., Huang, W., Latawiec, D., Jiang, K., Booth, D. M., Elliott,
V., et al. (2012). Review of experimental animal models of biliary
acute pancreatitis and recent advances in basic research. HPB 14, 73–81.
doi: 10.1111/j.1477-2574.2011.00408.x
Wang, Y., Kayoumu, A., Lu, G., Xu, P., Qiu, X., Chen, L., et al. (2016). Experimental
models in syrian golden hamster replicate human acute pancreatitis. Sci. Rep.
6:28014. doi: 10.1038/srep28014
Watanabe, O., Baccino, F. M., Steer, M. L., and Meldolesi, J. (1984). Supramaximal
caerulein stimulation and ultrastructure of rat pancreatic acinar cell: early
morphological changes during development of experimental pancreatitis. Am.
J. Physiol. 246, G457–467. doi: 10.1152/ajpgi.1984.246.4.G457
Weber, H., Merkord, J., Jonas, L., Wagner, A., Schroder, H., Kading, U., et al.
(1995). Oxygen radical generation and acute pancreatitis: effects of dibutyltin
dichloride/ethanol and ethanol on rat pancreas. Pancreas 11, 382–388.
doi: 10.1097/00006676-199511000-00010
Weidenbach, H., Lerch,M.M., Gress, T.M., Pfaff, D., Turi, S., and Adler, G. (1995).
Vasoactive mediators and the progression from oedematous to necrotising
experimental acute pancreatitis. Gut 37, 434–440. doi: 10.1136/gut.37.3.434
Wen, L., Javed, T. A., Dobbs, A. K., Brown, R., Niu, M., Li, L., et al. (2020). The
protective effects of calcineurin on pancreatitis in mice depend on the cellular
source. Gastroenterology 159, 1036–1050.e8. doi: 10.1053/j.gastro.2020.05.051
Wen, L., Javed, T. A., Yimlamai, D., Mukherjee, A., Xiao, X., and Husain, S. Z.
(2018). Transient high pressure in pancreatic ducts promotes inflammation and
alters tight junctions via calcineurin signaling in mice. Gastroenterology 155,
1250–1263.e1255. doi: 10.1053/j.gastro.2018.06.036
Wen, L., Voronina, S., Javed, M. A., Awais, M., Szatmary, P., Latawiec, D., et al.
(2015). Inhibitors of ORAI1 prevent cytosolic calcium-associated injury of
human pancreatic acinar cells and acute pancreatitis in 3 mouse models.
Gastroenterology 149, 481–492.e487. doi: 10.1053/j.gastro.2015.04.015
Werner, J., Laposata, M., Fernandez-del Castillo, C., Saghir, M., Iozzo,
R. V., Lewandrowski, K. B., et al. (1997). Pancreatic injury in rats
induced by fatty acid ethyl ester, a nonoxidative metabolite of
alcohol. Gastroenterology 113, 286–294. doi: 10.1016/S0016-5085(97)
70106-9
Werner, J., Saghir, M., Warshaw, A. L., Lewandrowski, K. B., Laposata, M., Iozzo,
R. V., et al. (2002). Alcoholic pancreatitis in rats: injury from nonoxidative
metabolites of ethanol. Am. J. Physiol. Gastrointest. Liver Physiol. 283, G65–73.
doi: 10.1152/ajpgi.00419.2001
Willemer, S., Elsasser, H. P., and Adler, G. (1992). Hormone-induced pancreatitis.
Eur. Surg. Res. 24 (Suppl. 1), 29–39. doi: 10.1159/000129237
Williams, J. A. (2001). Intracellular signaling mechanisms activated
by cholecystokinin-regulating synthesis and secretion of digestive
enzymes in pancreatic acinar cells. Annu. Rev. Physiol. 63, 77–97.
doi: 10.1146/annurev.physiol.63.1.77
Williams, J. A. (2002). Receptor biology and intracellular regulatory mechanisms
in pancreatic acinar cells. Curr. Opin. Gastroenterol. 18, 529–535.
doi: 10.1097/00001574-200209000-00002
Williams, J. A. (2019). Cholecystokinin (CCK) regulation of pancreatic acinar cells:
physiological actions and signal transduction mechanisms. Compr. Physiol. 9,
535–564. doi: 10.1002/cphy.c180014
Frontiers in Physiology | www.frontiersin.org 21 December 2020 | Volume 11 | Article 614591
Yang et al. Experimental Acute Pancreatitis Models
Williams, J. A., Korc, M., and Dormer, R. L. (1978). Action of secretagogues on a
new preparation of functionally intact, isolated pancreatic acini. Am. J. Physiol.
235, 517–524. doi: 10.1152/ajpendo.1978.235.5.E517
Wilson, J. S., and Apte, M. V. (2003). Role of alcohol metabolism in alcoholic
pancreatitis. Pancreas 27, 311–315. doi: 10.1097/00006676-200311000-00007
Wittel, U. A., Wiech, T., Chakraborty, S., Boss, B., Lauch, R., Batra, S. K.,
et al. (2008). Taurocholate-induced pancreatitis: a model of severe necrotizing
pancreatitis in mice. Pancreas 36, e9–21. doi: 10.1097/MPA.0b013e3181575103
Won, J. H., Zhang, Y., Ji, B., Logsdon, C. D., and Yule, D. I. (2011). Phenotypic
changes in mouse pancreatic stellate cell Ca2+ signaling events following
activation in culture and in a disease model of pancreatitis. Mol. Biol. Cell 22,
421–436. doi: 10.1091/mbc.e10-10-0807
Xia, X. M., Wang, F. Y., Wang, Z. K., Wan, H. J., Xu, W. A., and Lu,
H. (2010). Emodin enhances alveolar epithelial barrier function in rats
with experimental acute pancreatitis. World J. Gastroenterol. 16, 2994–3001.
doi: 10.3748/wjg.v16.i24.2994
Xiong, G. S., Wu, S. M., Wang, Z. H., Mo, J. Z., and Xiao, S. D. (2007).
Effects of thalidomide in experimental models of post-endoscopic retrograde
cholangiopancreatography pancreatitis. J. Gastroenterol. Hepatol. 22, 371–376.
doi: 10.1111/j.1440-1746.2006.04552.x
Xue, P., Deng, L. H., Zhang, Z. D., Yang, X. N., Wan, M. H., Song, B., et al. (2009).
Infectious complications in patients with severe acute pancreatitis.Dig. Dis. Sci.
54, 2748–2753. doi: 10.1007/s10620-008-0668-1
Yamaguchi, Y., Okabe, K., Liang, J., Matsumura, F., Akizuki, E., Matsuda, T.,
et al. (1999). The novel carboxamide derivative IS-741 reduces neutrophil
chemoattractant production by bronchoalveolar macrophages in rats with
cerulein-induced pancreatitis complicated by sepsis. Digestion 60 (Suppl. 1),
52–56. doi: 10.1159/000051454
Yamanel, L., Mas, M. R., Comert, B., Isik, A. T., Aydin, S., Mas, N., et al. (2005).
The effect of activated protein C on experimental acute necrotizing pancreatitis.
Crit. Care 9, R184–190. doi: 10.1186/cc3485
Yamano,M., Umeda,M., Miyata, K., and Yamada, T. (1998). Protective effect of the
combined treatment of pancreatic and neutrophil elastase inhibitors on acute
pancreatitis elicited by lipopolysaccharide in rats given intraductal injection
of taurocholate plus trypsin. Naunyn schmiedebergs. Arch. Pharmacol. 357,
558–564. doi: 10.1007/PL00005208
Yang, S., Imamura, Y., Jenkins, R. W., Canadas, I., Kitajima, S., Aref,
A., et al. (2016). Autophagy inhibition dysregulates TBK1 signaling and
promotes pancreatic inflammation. Cancer Immunol. Res. 4, 520–530.
doi: 10.1158/2326-6066.CIR-15-0235
Yang, Y. L., Li, J. P., Li, K. Z., and Dou, K. F. (2004). Tumor necrosis
factor alpha antibody prevents brain damage of rats with acute necrotizing
pancreatitis. World J. Gastroenterol. 10, 2898–2900. doi: 10.3748/wjg.v10.
i19.2898
Yuan, J., Tan, T., Geng, M., Tan, G., Chheda, C., and Pandol, S. J. (2017). Novel
small molecule inhibitors of protein kinase D suppress NF-kappaB activation
and attenuate the severity of rat cerulein pancreatitis. Front. Physiol. 8:1014.
doi: 10.3389/fphys.2017.01014
Yuan, Z., Meyerholz, D. K., Twait, E. C., Kempuraj, D., Williard, D.
E., and Samuel, I. (2011). Systemic inflammation with multiorgan
dysfunction is the cause of death in murine ligation-induced acute
pancreatitis. J. Gastrointest. Surg. 15, 1670–1678. doi: 10.1007/s11605-011-
1643-2
Zelner, I., Matlow, J. N., Natekar, A., and Koren, G. (2013). Synthesis
of fatty acid ethyl esters in mammalian tissues after ethanol exposure:
a systematic review of the literature. Drug Metab. Rev. 45, 277–299.
doi: 10.3109/03602532.2013.795584
Zhang, X., Jin, T., Shi, N., Yao, L., Yang, X., Han, C., et al. (2018).
Mechanisms of pancreatic injury induced by basic amino acids differ
between L-arginine, L-ornithine, and L-histidine. Front. Physiol. 9:1922.
doi: 10.3389/fphys.2018.01922
Zhang, X. P., Ye, Q., Jiang, X. G., Ma, M. L., Zhu, F. B., Zhang, R. P., et al.
(2007). Preparation method of an ideal model of multiple organ injury of
rat with severe acute pancreatitis. World J. Gastroenterol. 13, 4566–4573.
doi: 10.3748/wjg.v13.i34.4566
Ziegler, K. M., Wade, T. E., Wang, S., Swartz-Basile, D. A., Pitt, H. A., and
Zyromski, N. J. (2011). Validation of a novel, physiologic model of experimental
acute pancreatitis in the mouse. Am. J. Transl. Res. 3, 159–165.
Conflict of Interest: The authors declare that the research was conducted in the
absence of any commercial or financial relationships that could be construed as a
potential conflict of interest.
Copyright © 2020 Yang, Yao, Fu, Mukherjee, Xia, Jakubowska, Ferdek and Huang.
This is an open-access article distributed under the terms of the Creative Commons
Attribution License (CC BY). The use, distribution or reproduction in other forums
is permitted, provided the original author(s) and the copyright owner(s) are credited
and that the original publication in this journal is cited, in accordance with accepted
academic practice. No use, distribution or reproduction is permitted which does not
comply with these terms.
Frontiers in Physiology | www.frontiersin.org 22 December 2020 | Volume 11 | Article 614591
